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ABSTRACT
Sherman, Tyler. Comparative Host Response and Gene Regulation in Deer Mice
and Syrian Golden Hamsters During Acute Infection with Modoc Virus.
Published Doctor of Philosophy Dissertation, University of Northern
Colorado, 2020
Flaviviruses (family Flaviviridae, genus Flavivirus) comprise a diverse
group of globally-distributed viruses that may specifically infect vertebrates,
invertebrates, or both. Of those that can replicate in both invertebrates (such as
ticks and mosquitoes) as well as vertebrates (such as mammals), many
represent important human pathogens. Examples of these include dengue virus
(DENV), which may cause severe hemorrhagic fevers, West Nile virus (WNV),
Japanese encephalitis virus (JEV), and Zika virus (ZIKV), all of which may cause
febrile illness with neurologic involvement, and yellow fever virus (YFV), which
may induce hepatic dysfunction. Given that these viruses (among others) are
carried and transmitted by ubiquitous insects whose range is increasingly
expanding, hundreds of thousands of individuals worldwide are annually infected
and succumb to either disease or death. Further, despite monumental strides in
molecular research and medical practice over the preceding decades, vaccines
are limited, and treatment for those infected relies exclusively on supportive care.
While there are many obstacles to overcome in developing effective vaccines
and antiviral therapeutics, one particular challenge during flaviviral infection lies
in differentiating which aspects of the innate immune response lead to viral
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clearance or persistence and which may induce various immunopathologies. To
glean further understanding in this respect, the research outlined in this
dissertation utilizes two unique rodent models to investigate properties of viral
replication and immune gene expression during the early stages of infection with
a rodent-borne flavivirus (Modoc virus; MODV). By first examining these features
in the deer mouse (Peromyscus maniculatus), which serves as the putative
reservoir host of the virus in nature, it was discovered that viral RNA could be
detected from all of the tissues and fluids examined throughout the experimental
duration while infectious virus could be only be recovered from the kidneys,
spleen, liver, and brain at later timepoints. Concomitant with this, the profile of
select immune genes (IFN-γ, TNFα, IL-6, IL-10, and TGFβ) were shown to be
differentially expressed in the brain as compared to all other tissues. Likewise,
expression profiles significantly differed at a collection timepoint midway through
the experiment (day 6) compared to the first (day 1) and last (day 10) timepoint of
collection, suggesting that deer mice respond to MODV infection through a
tightly-regulated expression of innate immune genes that is both tissue- and
time-dependent. These features were then compared to those observed in Syrian
golden hamsters (Mesocricetus auratus), which, unlike the deer mice, develop
illness with neurologic involvement reminiscent of some flaviviral infections in
humans. In hamsters, the patterns of viral replication different from deer mice in
that the levels of MODV RNA were lower in all tissues at the first collection
timepoint but then surpassed the levels observed in deer mice by day 4 and
generally remained elevated throughout the remainder of the experiment.
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Although infectious virus could only be recovered from the kidneys and spleens
of infected hamsters, successful isolation was evident at all sampling timepoints
suggesting that hamsters are less able to control the production of viral progeny
in these tissues. In regard to gene expression, multivariate analysis depicts a
differential expression of the important antiviral cytokine IFN-γ between deer
mice and hamsters, a response which is especially evident in the brain tissue
beginning at day 6 post-infection. This finding may represent a potential
mechanism for immunopathology, which allows for increased viral dissemination
into the CNS following the breakdown of vascular integrity after elevated
proinflammatory signaling. All in all, there is hope that this research may
contribute to the greater scientific community’s collective understanding of
flaviviral pathology and provide a novel avenue to pursue in the development of
antiviral therapeutics.
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CHAPTER I
INTRODUCTION
Viruses such as West Nile virus (WNV), Japanese encephalitis virus
(JEV), dengue virus (DENV), and Zika virus (ZIKV), along with more than 70
additional representatives, comprise a group of clinically-relevant infectious
diseases. Although previously concentrated in the tropics of South America, subSaharan Africa, and South Eastern Asia, recent years have witnessed a
migration of these viruses into areas outside of their historically endemic range
(1). To exemplify this, the Center for Disease Control and Prevention (CDC) has
reported 1,594 cases of WNV neuroinvasive disease in the US during 2018 alone
(2). Concerningly, mortality subsequent to WNV infection rose to nearly 12%
during this period. Fortunately, laboratory-confirmed cases of symptomatic ZIKV
infection have witnessed a decline since the notable 2016 outbreak; however,
this virus continues to threaten equatorial countries around the globe and is of
particular concern for pregnant women (3). DENV is now considered to be the
most prevalent arthropod-borne virus in the world, with an estimated annual
incidence of severe disease and mortality in approximately 500,000 and 22,000
individuals, respectively (4, 5).
Despite numerous decades of research in an attempt to elucidate the
underpinnings of infectious disease, many characteristics of viral pathogenesis
remain incompletely understood. In large part, this challenge can be attributed to
14

the myriad of interactions which take place between a particular strain of virus
and the infected host. Indeed, it is known that the unique genetic landscapes of
each biologic entity strongly impact one another and ultimately influence the
emergence of clinical manifestations. What remains to be further clarified,
however, are the questions of which genetic elements are the most important
and how much variance can be tolerated before subclinical infection leads to
overt pathology.
Modoc virus (MODV) is a rodent-borne flavivirus initially isolated from deer
mice in Modoc County, California. While infection with MODV is not typically
considered a notable threat to the general public, there has been at least one
documented case in which MODV led to neurologic disease in a young boy (6).
Notwithstanding the general lack of human disease induced by this virus, there
exists many genetic similarities between MODV and other, more virulent
flaviviruses. This considered, research with MODV offers a unique avenue to
supplement our current understanding of flaviviral infection and disease. When
coupled with the use of comparative rodent models, it is possible to examine
features of the disease process and subsequent immune response in a more
complete, holistic manner. This research aims to accomplish the aforementioned
goal by conducting experimental infections with MODV in deer mice, which resist
disease from the virus, as well as Syrian golden hamsters, which recapitulate
human-like illness once infected (7, 8). During an acute experimental infection
period, tissues and excrement samples are collected and analyzed to examine
two fundamental aspects of virological research: a) where and how quickly does
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the virus replicate and b) on the molecular level, how does the host respond?
Answering these questions, especially in the context of comparative model
systems, may provide novel information in regard to the greater scientific
community’s understanding of flavivirus pathology. Ultimately, it is the hope that
examining these viral infections through a unique lens will help to bolster the
future development of vaccines or antiviral therapeutics.
A1

Review the flavivirus literature to define present framework of
knowledge and attempt to identify gaps in current understanding of
flaviviral pathology.

H1

As most research conducted to date has utilized inbred rodent
models and serially-passaged isolates of lab-kept flaviviruses, there
may be value in the development of unique and comparative model
systems. Reviewing the literature and synthesizing an in-depth
framework of understanding will help to reveal areas where
research with flaviviruses is lacking, thereby providing the impetus
for the development of novel research approaches.

A2

Examine aspects of host pathology, characterize viral replication
kinetics, and investigate the expression of select immune genes in
deer mice during acute experimental infection with Modoc virus
(MODV).

H2

As the putative reservoirs of MODV, it is hypothesized that deer
mice will demonstrate no signs of clinical pathology throughout the
experimental duration. Likewise, despite the absence of any overt
pathologies, infectious virus and viral RNA should be detectable in
various tissues at multiple timepoints; however, quantities of
detectable virus will be sustained at relatively low levels. Finally, it
is hypothesized that the relative expression values of immune
genes will vary across tissues and over time, thereby eliciting a
tissue- and time-specific protective effect against both viral burdens
as well as immunopathologies that may accompany a sustained
proinflammatory response.
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A3

Compare aspects of host pathology, viral replication kinetics, and
immune gene expression between deer mice and Syrian golden
hamsters at multiple timepoints during acute experimental infection
with MODV.

H3

It is hypothesized that Syrian golden hamsters will demonstrate
clinical signs of pathology when infected with MODV, thereby
constituting a comparative pathogenic model. As such, viral loads
should differ significantly in various tissues over time when
compared to deer mice. Finally, the relative expression values of
immune genes should differ significantly between hamsters and
deer mice in various tissues at distinct timepoints throughout the
experimental duration, highlighting the different modalities of
immune regulation elicited by each rodent model even when
pathogen dose and route of infection are standardized.
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CHAPTER II
REVIEW OF THE FLAVIVIRUS LITERATURE
Abstract
Flaviviruses (family Flaviviridae, genus Flavivirus) are one of the oldest
lineages of zoonotic viruses studied to date. Most medically-important examples,
such as dengue virus (DENV) or West Nile virus (WNV), are vectored by
mosquitoes, although others, such as tick-borne encephalitis virus (TBEV), are
transmitted by ticks. Further, there exists a small intrageneric clade of nonvectored representatives, such as Modoc virus (MODV) or Rio Bravo virus
(RBV), that are transmitted directly from reservoir hosts like rodents and bats,
respectively. Indeed, flaviviruses have been isolated from nearly every continent
across the globe and comprise more than 40 distinct species that have been
documented to cause disease in humans and domesticated animals. Although
the majority of infections result in only sub-clinical or mild disease, various
flaviviruses have periodically caused notable regional outbreaks. During these
epidemics, infected populations may exhibit a broad range of clinical pathologies,
the most severe of which include hemorrhagic fevers or illness with neurologic
involvement. Despite many years of laboratory and clinical research utilizing a
multitude of model systems, the exact mechanisms of most flaviviral pathologies
remain incompletely understood. For example, while it is known that genetic
polymorphisms, found in both the virus as well as the host, have the potential to
18

strongly influence the outcome of clinical disease, the observed variance that
exists among these interactions make it difficult to pinpoint which polymorphisms
are the most impactful. As well, it is now clear that the immune system itself may
contribute to disease under the context of many flaviviral infections; however, the
degree to which this occurs, as well as the precise alterations in the immune
response that lead to either viral clearance or disease exacerbation, appear to be
extremely virus-host specific and therefore present a significant challenge in the
development of antiviral therapeutics aimed at protecting large populations. In
light of these obstacles, it appears that there is a need to continue developing
diverse model systems that allow for the extrapolation of research data which
accurately reflects the genetic diversity present in human populations. One way
to accomplish this aim might be to implement the use of non-traditional rodent
models (e.g., deer mice, golden hamsters, etc.) that are maintained in relatively
outbred stocks as compared to the frequently-used inbred strains of the domestic
laboratory mouse (Mus musculus). Finally, there could be value in the use of
divergent flaviviruses, such as those belonging to the non-vectored clade, as
comparative models that help to distinguish any subtle but universal
discrepancies in the flaviviral genome or replication cycle that most significantly
impact the outcome of disease.

19

Flaviviruses
Shortly following the widespread acceptance of germ theory in the late
1800s came the conscious awareness that certain diseases may be carried and
transmitted to new hosts through intermediate vectors. Consequently, this
realization occurred nearly concomitant with the onset of virology as a research
discipline, arguably pioneered by the U.S. Army physician Walter Reed (among
others) during his work in Panama. Due to the prevalence of hemorrhagic fevers
that continuously claimed the lives of canal workers, Reed sought to elaborate on
the hypotheses of Carlos Finlay, a Cuban doctor who postulated that mosquitoes
(rather than direct contact) might, in fact, facilitate the spread of disease. In time,
Reed’s investigations led to the discovery of yellow fever virus (YFV), the
prototype virus that would later establish one of the most pervasive groups of
viruses on the entire planet (9, 10).
As of 2017, a total of 89 distinct species have been described within the
family Flaviviridae (11). This taxonomic collective of viruses has been further
divided into four discrete genera on the basis of serologic cross-reactivity, unique
biologic interactions, and minor discrepancies in viral genome organization and
replication strategy (11, 12). Like the prototypic YFV, after which the family was
named (the Latin flavus referring to the jaundiced appearance of diseased
individuals), most representatives become recognized as medically-relevant
when horizontal transmission to susceptible hosts (e.g., humans and other
mammals) occurs through the feeding of hematophagous arthropods such as
ticks and mosquitoes. For this reason, flaviviruses are sometimes referenced
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along with other, non-related viruses (e.g., togaviruses) as the arboviruses
(arthropod-borne viruses) (13).
Fortunately, the vast majority of flaviviral infections are speculated to selfresolve following only mild or subclinical illness; however, instances of severe
disease are not uncommon and, depending on the specific virus, may result in
multiple-organ failure, autoimmune disorders, malformations in fetal
development, hemorrhagic fevers with vascular leak syndromes, or
meningioencephalitic ailments with the potential for permanent neurologic
sequelae (11). Notable representatives of the Flavivirus genus include dengue
virus (DENV), West Nile virus (WNV), tick-borne encephalitis virus (TBEV), and
Japanese encephalitis virus (JEV), as well as the increasingly recognized Zika
virus (ZIKV). Other members of the Flaviviridae family include hepatitis C virus
(HCV) of the Hepacivirus genus and GBV-A virus of the Pegivirus genus, both of
which are transmitted to new hosts exclusively through the intermixing of bodily
fluids (14). Lastly, members of the Pestivirus genus (e.g., bovine viral diarrhea
virus, BVDV) are best known for their ability to elicit economically significant
disease in ruminant animals with only rare instances of spillover into novel
mammalian hosts (15, 16). The remainder of this literature review will focus
solely on the current knowledge of the Flavivirus genus unless otherwise noted.
Flavivirus Taxonomy, Structure and Replication
Various members contained within the Flavivirus genus exhibit astonishing
dissimilarity in regard to nucleotide sequence and viral ecology. In one of the
most extensive studies conducted to date on the organization of these viruses,
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Kuno et al. describe a schematic in which the genus can be further categorized
into the descending hierarchy of clusters (determined by 95% bootstrap cutoffs
and vector-host associations), clades (groups which share ≥ 69% (wholegenome) sequence identity among one another) and species (groups with share
> 84% (whole-genome) sequence identity) (Table 2.1) (17). Finally, Kuno et al.
(17) denote viral strains as isolates from distinct geographic areas where a
particular species is known to be endemic. As can be expected from RNA
viruses, even strains within a species may exhibit remarkable variation (e.g. a
maximum of 14% nucleotide dissimilarity between strains of YFV) (17).
Nevertheless, there are numerous conserved features that unite the taxon as a
whole.

22

Table 1

Table 2.1: Assignment of flaviviruses to clusters and clades. Note. Modified
table from Kuno et al. demonstrating the various clades, vectors, and
distributions of distinguished representatives from the genus Flavivirus. Of
particular note are the updated distributions of each representative based on
current surveillance records available at the time of writing this review (17).
Virus

Clade

Traditional Vector a

Distribution

Non-vector Cluster
San Perlita
Modoc
Rio Bravo

I
II
III

N (rodent)
N (rodent)
N (bat)

Texas
Western US
US, Mexico

Tick-borne Cluster
Powassan
Tick-borne encephalitis

IV
IV

Tick, mosquito
Tick (Ixodes spp.)

North America, Russia
Russia, Europe, Asia

Mosquito-borne Cluster
Yellow fever
Dengue-1 to -4
Zika
West Nile
Japanese encephalitis

VII
VIII
X
XIV
XIV

Mosquito (Aedes spp.)
Mosquito (Aedes spp.)
Mosquito (Aedes spp.)
Mosquito (Culex spp.)
Mosquito (Culex spp.)

Tropical regions
Africa, Americas, Australia
Asia, Africa, Americas
Global (Temperate to Tropics)
Asian and parts of the Pacific

In vitro and in vivo evidence suggests that some MBFVs can be recovered from non-traditional
vectors.
a

Universally, flaviviruses are distinguished as spherical, lipid-enveloped
virions which contain a positive-sense RNA genome within a virally-encoded
nucleocapsid (C) protein (11) (Figure 2.1). Immediately external to the lipid
bilayer are the virally-encoded and tightly-associated matrix (M) and envelope (E)
proteins, the combination of which encompasses a mature virion that ranges in
size from approximately 40 to 60 nm. The flaviviral genome (generally 10-11 kb
in length) encodes a single polyprotein within an open reading frame (ORF) that
is co- and post-translationally cleaved by host and viral proteases to form the
three structural proteins (C, M, and E) and at least seven non-structural proteins
(NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) (Figure 2.2). Flanking the
ORF on the 5’ and 3’ ends of the genome are untranslated regions (UTRs) of
approximately 100 and 400-700 nucleotides, respectively. Contained within the 5’
23

UTR is a conserved, Y-shaped, stem-loop A structure (SLA) believed to aid in
viral replication by binding to complementary sequences in the 3’ end and
circularizing the viral genome (18). Beyond the SLA, the 5’ end is covered by a
type I methyl cap that closely resembles those of host cell transcripts.
Importantly, this cap serves the multipurpose role of preventing cytosolic
degradation by passive exonucleases, inhibiting viral recognition within the cell
and subsequent degradation by host antiviral proteins, and by recruiting host cell
translational machinery. On the opposite end, the 3’ UTR contains a stem-loop
(SL) structure, which acts as the initiation site for negative-sense RNA synthesis.
Finally, most flaviviruses contain a non-coding RNA downstream of the SL that is
likewise multifunctional (e.g. sfRNA; see section titled “Flavivirus Immune
Subversion and Host Pathology”) followed by a 3’ hydroxyl tail. Interestingly,
while the presence of SLA and SL structures remain conserved across all
examined flaviviruses, minor discrepancies in their sequences (as well as
additional structures) in the 5’ and 3’ UTRs between representatives have been
posited to elicited some of the variable pathogenesis witnessed during clinical
infection (18, 19).
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1.12.1

Figure. 2.1: Schematic representation of a typical virion from the genus
Flavivirus. (A) Depicts RNA genome contained within capsid proteins layered
beneath the lipid membrane. Immature virions (left) maintain prM “caps” over E
proteins to prevent preemptive fusion of viral progeny within host cell secretory
pathways. In contrast, E proteins in mature virions (right) are anchored to the
lipid membrane by prM-derived M proteins following cleavage by host proteases.
“Anchor” and “stem” indicate discrete domains within the E protein as
characterized by soluble forms of E (sE). (B) Computer-generated model of
complete (mature) DENV 2 virion in which different shades indicate each of the
three E protein domains. Modified from Vratskikh et al., 2013 (20).
As depicted in Figure 2.1, mature virions utilize a unique architecture in
which E proteins lay parallel to the lipid bilayer in a “herringbone” configuration.
These proteins form ninety head-to-tail homodimers that undergo rotational
rearrangement during final virion maturation to create environmentally-stable
particles with icosahedral symmetry (21). Each E protein itself contains three
structural domains: ED-I, ED-II, and ED-III. Virions are believed to accomplish
fusion within pre-lysosomal endocytic vesicles via a fusion loop contained within
the ED-II domain, while the ED-III domain acts as the primary antigenic epitope
recognized by neutralizing antibodies (22). ED-I represents the central structural
domain of the E protein and contains glycosylation sites (determined by specific
25

hosts and viral strains) that are speculated to influence virion pH sensitivity and
neuroinvasiveness (22). In addition to the E protein, virions display a superficial
membrane (M) protein created by proteolytic cleavage of the pre-membrane
(prM) protein during viral maturation along the cellular exocytic pathway.
While it has been established that the E protein facilitates virus binding to
susceptible host cells, the exact process by which virions are internalized is
incompletely understood. In contrast to other well-studied viruses for which bona
fide cognate receptors have been clearly elucidated, it is suggested that many
flaviviruses may instead utilize multiple binding partners to aggregate on a cell’s
surface before undergoing receptor-mediated endocytosis in either a clathrindependent or -independent manner (23, 24). Among these putative binding
receptors are glycosaminoglycans (GAGs), such as heparan-sulfate and
syndecans, which are expressed in high concentrations on nearly all cell
surfaces and may, therefore, provide a rationale for the broad spectrum of tissue
tropism by flaviviruses (23). Virion aggregation in this fashion is most likely a
consequence of electrostatic attraction between positive and negative residues
on the lateral surface of the E protein and sulfate groups on the polysaccharides
of GAGs, respectively (25). However, while GAGs may contribute to the lowaffinity virion aggregation on the cellular surface, their inability to initiate receptormediated endocytosis suggests that alternative receptors are required for viral
entry. Additional co-receptors known to facilitate flaviviral attachment include the
C-type lectin receptors (CLRs), a class of pattern-recognition receptors (PRRs)
expressed on myeloid-derived cells that recognize carbohydrate motifs found on
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some pathogenic organisms (23). Of these PRRs, mannose receptors (MRs),
dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrins
(DC-SIGNs), and liver/lymph node-specific ICAM-3 grabbing non-integrins (LSIGNs) have all been implicated during in vitro infection of mammalian cells lines
(23, 26). Lastly, binding to αvβ3 integrins has been demonstrated for WNV (27);
however, along with the aforementioned CLRs, productive infection of cell lines
lacking these receptors further supports the notion that additional receptors or
activation factors are needed to initiate endocytosis following viral adsorption (28,
29). In any case, it is important to note that the ability for some flaviviruses to
utilize various receptors conserved throughout multiple phyla (e.g. invertebrates
and vertebrates) serves as an important contribution to the viral ecology of these
relatively promiscuous pathogens.
Once internalized, virions are trafficked through the endocytic pathway,
where a decrease in pH induces rearrangement of E protein homodimers and
facilitates the fusion of viral and host-cell lipid membranes (Figure 2.3) (30).
Following the dissolution of the nucleocapsid and release of viral nucleic acids
into the host cytoplasm, viral RNA is targeted to the endoplasmic reticulum (ER),
where the ~3400 amino acid polyprotein weaves through the ER membrane
during translation (Figure 2.2). For most members, initiation of translation occurs
via ribosomal scanning in a cap-dependent manner; however, the finding that
DENV may circumvent cap dependency suggests that other flaviviruses may be
able to as well (19). Further, it has been demonstrated with DENV that a small
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hairpin loop in the C gene facilitates ribosomal pausing over authentic start
codons (i.e. AUG) in lieu of the typical eukaryotic Kozak motif (31).
A

B

C

3
Figure 2.2: Schematic representation of genome organization and
polyprotein translation for members of the Flavivirus genus. (A) Depicts
genomic polyprotein with 5’ UTR, cap and SLA on N-terminal end (left) along with
3’ UTR containing the SL, sfRNA, and hydroxyl tail on C-terminal end (right). (B)
Organization of structural (C, prM/M, and E) and nonstructural (1, 2A, 2B, 3, 4A,
4B, and 5) proteins along with respective cleavage sites from host and viral
proteases. (C) Depicts orientation of translated polyprotein throughout ER
membrane along with respective cleavage sites; top of image represents ER
lumen while the bottom represents the host cell cytoplasm. Modified from Fields
et al., 2007 (32).
Upon translation and proteolytic cleavage, flaviviral nonstructural proteins
contribute to the production of progeny virus through the induction of cellular
remodeling and host immune subversion. Namely, the formation of vesicle
packets (VPs) within convoluted membranes of the host ER is thought to provide
a “place of refuge” for viral intermediates such as dsRNA (Figure 2.3 inset) (33,
34). Electron tomography studies conducted with DENV have revealed that VPs
fully encompass viral components save for small cytoplasmic pores situated in
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close proximity to distinct regions of viral budding from ER membranes (35).
Indeed, it has been suggested that these sites of co-localization increase viral
replication efficiency by concentrating the NS proteins and other required
components (e.g. host factors); however, further speculation has led to the
working hypothesis that cellular remodeling in this manner may be a convergent
strategy of diverse RNA viruses in which cytoplasmic replication drives the need
to protect viral intermediates against passive immune surveillance (33). Lastly,
the co-opted use and differential expression of cholesterol-synthesizing enzymes
such as hydroxy-methylglutaryl-CoA reductase (HMGCR) during flavivirusinduced cellular remodeling have been demonstrated to contribute to viral
pathology by interfering with the host cell’s ability to respond to antiviral signaling
(36). As cholesterol is relocated away from surface membranes, lipid rafts (i.e.
distinct regions of conglomerate, membrane-bound lipids, and proteins) lose
functionality as sites of signal transduction in response to antiviral cytokines such
as the interferons (see the section titled “Pathogen Recognition and Antiviral
Signaling”). Aside from cellular remodeling, additional knowledge on the direct
and indirect methods of immune subversion by flaviviruses are detailed later in
this review.
Assembly of nascent virions likewise occurs within VPs as the structural
proteins start to accumulate within luminal membranes, and NS proteins (e.g.
NS2A and NS3) begin to coordinate the shift from viral replication to packaging
(37). Through the use of cryogenic electron microscopy, the working explanation
of virion morphogenesis suggests that cytoplasmic C protein dimers associate
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with viral RNA in regions near E-prM heterodimers (at the time still bound to ER
membranes via C-terminal anchor sequences) (38, 39). Budding of looselystructured nucleocapsids into the ER lumen allows for the acquisition of a ERderived lipid envelope containing a dense arrangement of pr-E heterodimers. As
a point of scholarly interest, viral assembly in this manner is not uncommon;
however, while the process is extremely rapid, theoretically producing up to
hundreds of thousands of nascent virions within minutes, viruses must also
contend with the inefficiency that accompanies packaging at such speeds. For
example, premature assembly of nucleocapsids may lead to the production of
virus-like particles containing truncated genomes or no RNA at all. While some of
these “empty shells” are simply immunogenic, those which contain sub-genomic
portions (termed defective interfering (DI) particles) may actually enhance the
infectivity of their wild type counterparts (40, 41). Nevertheless, budding virions
are shuttled to the Golgi and through a secretory pathway equivalent to that used
by newly synthesized host proteins destined for the plasma membrane (42-44).
Along the way, E proteins are occasionally glycosylated, a modification that has
been shown to alter viral tropism and virulence in certain contexts (45). Upon
entering the later stages of transport, the host protease furin catalyzes the
structural maturation of immature virions by cleaving the pr domain from the M
protein (46). At this time, it is believed that conservation of the pr-E heterodimers
until just prior to release is necessary to prevent the acid-catalyzed
rearrangement of E homodimers found on mature virions during trafficking
through acid compartments along the secretory pathway (47).
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Figure 2.3: Schematic overview of the general replication cycle for
members of the genus Flavivirus (48). Of particular note are the vesicle
packets (VP) formed along the perinuclear region of the ER membrane during
viral replication and translation. In addition to shielding viral components from
passive immune surveillance, VPs concentrate nonstructural proteins to form a
replisome complex (lower right inset) (49). As well, the presence of immature
virions and soluble pr proteins in the extracellular environment can be seen
leading to the production of non-neutralizing antibodies and subsequent disease
through antibody-dependent enhancement (ADE). Images modified from Pierson,
2012, and Shi, 2014.
Flavivirus Phylogeny, Ecology and Distribution
As alluded to above, flaviviruses offer an interesting example of the
dynamic interplay between genotype and the environment. Overall, the genetic
blueprint of the genus remains conserved enough that representatives can be
distinguished from one another when coding regions are subjected to
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phylogenetic analysis by either maximum-likelihood or neighbor-joining methods
(18, 50). Observing these analyses reveals consistent trends that indicate insectspecific (ISFV), no known vector (NKV), and tick-borne (TBFV) clusters all
represent monophyletic groups while the mosquito-borne (MBFV) cluster remains
less resolved (Figure 2.4). Despite this, clades within the MBFV cluster retain a
certain level of stability that reflects a corresponding vector at the genus level
(e.g. Aedes vs. Culex spp.). Perhaps unsurprisingly, examining the entire
nucleotide sequence of select representatives (17) does not appear to improve
the resolution of these clades any further; however, the persistence of
phylogenetic grouping that adheres to both sequence identity as well as vector
specificity adds support to the hypothesis that conserved elements (e.g. SLA and
sfRNAs) in non-coding regions may additionally contribute to important features
of flaviviral ecology (18, 51, 52). Likewise, cross-examinational studies both in
vivo and in vitro have clarified that while diverse mosquito vectors may be
susceptible to MBFVs outside of their historical range (e.g. DENV in Culex spp.
or WNV in Aedes spp.), viral titers recovered from these alternative vectors are
typically lower and therefore suggest a reduced competency for transmissive
ability concomitant with support for the coevolution of MBFV with their traditional
vectors (53, 54).

32

5
Figure 2.4: Phylogenetic representation of the genus Flavivirus based on
maximum-likelihood analysis from coding regions. Predicted amino acid
substitutions per site are indicated by the scale bar. Of particular note are the
monophyletic clades comprised of insect-specific, no known vector, and tickborne representatives compared to the relatively unresolved mosquito-borne
clade. Despite the poor resolution, however, there appears to be some level of
phenotypic selection that favors the maintenance of various mosquito-borne
members within specific vectors at the genus level. Modified from Bolling et al.,
2015 (50).
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Due to their medical relevance, MBFVs and TBFVs have been studied
extensively and are known to exhibit varying degrees of replication efficiency and
host pathogenesis in both vertebrate and invertebrate tissues and/or cell lines.
Alternating between such disparate hosts highlights a remarkable adaptation of
these viruses given their ability to utilize divergent cellular machinery while also
subverting host-specific immune responses. Perhaps the most extraordinary
example of this comes from WNV, which, despite a predominant circulation in
various avian species, has been documented to additionally infect humans,
equines, and at least in one instance, a captive orca (55). Due to low
transmissive probability, humans and equines are viewed as “dead-end” hosts
when infected with WNV; however, birds may act either as reservoirs or
amplifying hosts of WNV, providing either a persistence or high-titer source of
virus for ornithophilic mosquitoes, respectively (56). Although rare, WNV has
even been recovered from multiple tick lineages while feeding on wild birds (57,
58).
Similar to WNV, there exists a collective agreement that birds (along with
pigs) may act as reservoirs or amplifying hosts of JEV (59). In contrast, other
MBFVs such as YFV appear to abide by a more restrictive host range in which
non-human primates (NHPs) serve as the primary reservoir. In this instance, the
movement of virus between mosquitoes and NHPs denotes a transmission cycle
identified as “jungle yellow fever,” while spillover and subsequent circulation in
humans are sometimes referred to as “urban yellow fever” (60). Similarly, NHPs
serve as the ostensible reservoirs of DENV and ZIKV (4, 61). Distinguishing the
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two from one another, however, is lack of evidence supporting that vertebrates
other than NHPs can be infected by DENV in nature while antibodies against
ZIKV have been recovered from domestic sheep and goats, horses, cows, ducks,
rodents, bats, orangutans, and carabaos (61). Nonetheless, a failure to establish
persistent viral infection along with an inherent ability to resist disease from
DENV and ZIKV further indicates that rodents are unlikely reservoirs of these
MBFVs (61, 62).
Apart from the aforementioned considerations which govern the viral
ecology of MBFVs and TBFVs in diverse hosts, additional mechanisms that
perpetuate the existence of these viruses in nature include instances of vertical
transmission, non-vectored horizontal transmission, and although uncommon,
infection through contact with blood products, aerosols, or following consumption
of unpasteurized human and animal milk (11, 63). For arthropods, vertical
transmission may occur transovarial (from parent to offspring) or transstadial
(from one life stage to the next), both of which are important for ISFVs given their
failure to replicate in vertebrates and thus, in contrast to MBFVs and TBFVs, an
inability to rely on transmission to uninfected insect hosts through vertebrate
intermediates (50). Intriguingly, the selective pressure for vertical transmission
does not appear to hold true for NKVs despite a similar paradigm in which only
vertebrate tissues and cell lines are permissive to infection (64). In the case of
NKVs, experimental infection of rodent mothers either failed to produce sufficient
virus or antibody titers in offspring or, in one case, led to fetal pathogenesis,
which contradicts support for vertical transmission in nature (64, 65). Rather,
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NKVs appear to favor non-vectored horizontal transmission in which virus is
spread through either direct or indirect contact. Support for these observations is
primarily derived from studies involving the cohabitation of experimentally
infected and non-infected individuals. In support of direct contact (i.e. grooming
and/or fighting), virus was recovered from the lung tissue and salivary glands of
infected rodents; indirect contact (e.g., fomites and aerosols), on the other hand,
is corroborated by the finding that virus can be shed in the urine as well as saliva
(7, 8, 66). That being considered, it is curious to note that one of the most wellstudied NKVs, Modoc virus (MODV), was initially isolated from the mammary
glands both experimentally- and naturally-infected deer mice (8, 67) and that at
least one investigation has demonstrated the possibility of vertical transmission
through the consumption of breast milk by suckling pups (64).
Transmission through contact with animal products such as milk is less
convoluted in the case of infection by TBEV, an occurrence which has led to a
number of small outbreaks following the consumption of unpasteurized dairy
products from domestic ruminants in parts of Europe (68-70). Moreover, WNV
transmission has been documented to occur through human breastfeeding in at
least one case from a mother that received a transfusion of donated blood
following infant delivery (71). These examples not only highlight the ability for
some flaviviruses to utilize atypical routes of transmission (e.g., intragastric) but
also emphasize the need to execute surveillance and precautionary measures
when handling blood products from subclinically-infected individuals. To this end,
many studies have now verified the prevalence of WNV-positive samples from
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otherwise healthy blood donors (72, 73). Finally, there have been increasing
reports of intrauterine, intrapartum, or sexual transmission; while most of these
cases involve infection with ZIKV, the involvement of reproductive organs or
developing fetuses is not unprecedented for flaviviruses and has been
additionally observed for DENV, WNV, and JEV as well as some of the NKVs
(74-77). Needless to say, the apparent diversity of transmissive potential for
members of the Flavivirus genus represents a complicated, albeit fascinating,
paradigm of viral ecology for which there is much still to learn.
In regard to distribution, recent years have witnessed a frightening
migration of clinically-important flaviviruses into areas outside of their historically
endemic ranges (1). Here, YFV may serve again as the prototype example;
however, in this context, the impact of human movement around the globe
underscores the potential consequence of inadvertently transporting deadly
pathogens. Believed to have originated in Africa, it is now understood that the
slave trade was likely responsible for introducing (and perhaps contributing to the
dissemination of) YFV to the New World (60). Currently, YFV is considered
endemic in the vast majority of South American and Central African countries
(78). Indeed, a threat remains even from the flaviviruses for which a vaccine
exists. This is highlighted by a lingering outbreak of YFV beginning in 2016,
which required the administration of more than 28 million vaccine doses, thereby
exhausting the global YFV vaccine supply and prompting the Eliminate Yellow
Fever Epidemics (EYE) initiative by the World Health Organization (WHO) (79).
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Figure 2.5: Global distribution of medically-important flaviviruses as
reported by 2017. (A) Depicts overlapping distribution (orange) of TBEV (pink)
and JEV (yellow). (B) Depicts widespread distribution of WNV. (C) Depicts
overlapping distribution (dark green) of ZIKV (light green) and DENV (blue).
Modified from Collins and Metz, 2017 (10).
Similarly, the infection incidence of TBEV, for which the risk of exposure
extends throughout the entirety of Russia, Mongolia, China, and Japan,
continues to grow despite the availability of a licensed vaccine (Figure 2.5) (10).
JEV overlaps these regions of East Asia (excluding Mongolia but including the
Korean peninsula), extending down through Southeast Asia (including India) and
into Northern Oceania. In one estimate, it was proposed that JEV is responsible
for lasting neurologic sequelae or death in approximately 34,000 cases annually,
primarily affecting children under the age of 15 (80). These numbers are
particularly disturbing given the inclusion of a JEV vaccine administered as part
of routine pediatric immunizations in countries like China (81). Likewise, the
global distribution of WNV has expanded to include both Eastern and Western
hemispheres, reaching from Central America into Canada and covering nearly all
of Europe, Africa, Oceania, and some parts of South America. To exemplify this,
the Center for Disease Control and Prevention (CDC) has reported 46,086 cases
of clinical WNV disease in the U.S. from 1999 to 2016, a staggering incidence
given the absence of this virus in North America prior to the turn of the 21 st
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century (82). Locally-acquired cases of ZIKV infection in Florida and Texas
during 2017 further illustrate the continuing spread of flaviviruses into novel
environments (3). At present, DENV and ZIKA share similar distributions as
WNV, excluding Europe but including practically all of South America (10). With
nearly 40% of the global population at risk, DENV is considered the most
prevalent vector-borne virus in the world, infecting more than 400 million
individuals annually (4, 5).
Causes for the widespread distribution and expanding range of
flaviviruses across the world are multifold and synergistic. As alluded to above,
the increasing ease and frequency for which humans now transverse the globe
has led to the unfortunate propagation of pathogens into regions previously
devoid of these disease-causing agents. This piece of the epidemiologic puzzle
does not end with the movement of individuals themselves; however, as with
many human activities, may indirectly contribute to the prevalence of flaviviral
disease through anthropogenic influence on the environment. For example,
multiple investigations have found that international shipments of used
automotive tires may harbor the eggs and larvae of viral-infected mosquitoes,
thereby facilitating the invasion of flaviviruses into new areas (83, 84). In line with
this, it could be argued that the prevalence of water-bearing plastic waste in
virtually all environments offers endless breeding opportunities for mosquitoes
unable to procreate in otherwise arid locations. This occurrence is compounded
by increasing global temperatures and subsequent variations in regional
precipitation, which further permit the range expansion of arthropods (Figure 2.6)
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(85-88). Finally, population growth, cohabitation with domestic livestock, and the
unrelenting encroachment (i.e. urbanization) of humans into environments like
the equatorial tropics, which harbor the highest diversity of zoonotic pathogens
(i.e. disease agents which come from animals), all ensure that novel viruses will
continue to emerge or re-emerge (89, 90).

7
Figure 2.6: Locations in the US of present-day and predicted future
suitability for the Aedes aegypti mosquito. Regions for present-day habitat
were created using surveillance reports from 1950 to 2000, while predicted future
habitat was inferred based on the Representative Concentration Pathway 8.5
(RCP8.5) model of climate change. Modified from Monaghan et al., 2016 (91).
Modoc Flavivirus
Given the use of Modoc virus (MODV) as the model representative for this
study, it seems fitting to include a short review of the history and current
knowledge surrounding this particular flavivirus. MODV was first isolated from the
mammary gland tissue of a wild deer mouse (Peromyscus maniculatus, mouse
M544) trapped in Hackamore forest, Modoc County, California, in July of 1958
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(92). Since that time, successive isolates have been recovered exclusively from
deer mice in Colorado, Oregon, and Montana, as well as Alberta, Canada (6, 93).
Preliminary serologic evidence clarified MODV as a member of the group B
arboviruses (i.e. flaviviruses) along with representatives such as YFV and DENV
(67). Unlike the latter, though, MODV cannot replicate in invertebrate cells and
therefore belongs to clade II of the no known vector (NKV) cluster within the
genus Flavivirus (Table 2.1) (17). At present, the complete genome of MODV has
been sequenced and used to confirm its previous taxonomic assignment as well
as distinguishing features that characterize this virus apart from other
representatives both with and without arthropod vectors (94).
Coincidentally, the initial discovery of MODV occurred by happenstance
during field studies in which wild-caught rodents were being examined for
Colorado tick fever virus (CTV) (67). Subsequent to preliminary tests which
placed MODV in group B of the arboviruses, early laboratory work aimed to
elucidate the ecology of this virus by first (unsuccessfully) attempting to infect
mosquito cell lines and later by examining viral tissue tropism to gain clues about
the transmission of this virus in nature (67). In brief, tissue tropism appears highly
dependent on the exact rodent model utilized. For deer mice, which are
presumed to be the natural reservoirs of MODV, virus preferentially replicates to
higher and more sustained titers in the lungs, spleen, and salivary/submaxillary
glands following experimental challenge through either the intranasal (8) or
intramuscular route (unpublished results). As well, infectious virus has been
recovered from the lactating mammary glands of both naturally- and
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experimentally-infected deer mice, although transplacental infection in pregnant
mothers does not seem common (8, 67). Finally, while MODV can sometimes be
recovered from the kidneys and urine of infected deer mice, mean viral titers and
prevalence of successful isolations among replicants are lower than the
previously referenced organs (8, 92). Taken together, these findings suggest that
the natural circulation of MODV among wild deer mice likely occurs at low levels
through close direct contact when performing activities such as grooming, eating,
or nursing.
Other investigations have conducted in vitro and in vivo experimental
infections with MODV in Syrian golden hamsters and SCID or NMRI strains of M.
musculus (65, 92, 95). Similar to studies with deer mice, tropism of MODV
toward the salivary glands occurs in both golden hamsters and SCID mice;
however, while tropism toward kidney and lung tissues is apparent in golden
hamsters but relatively lacking in SCID mice, the opposite is true for tropism
toward the spleen in SCID mice as compared to golden hamsters when
inoculation dosage and routes are standardized. For hamsters, MODV has been
recovered from kidney tissues up to 8 months post-infection with varying
durations of accompanying viruria ranging from 5 to 150 days post-inoculation (7,
66). Further, inoculation of SCID and NMRI mice, as well as golden hamsters,
reveals a pathogenic neurotropism of MODV that does not seem to occur in deer
mice (8, 66). Indeed, a separate study has likewise shown that infection of
golden hamsters with MODV leads to CNS involvement reminiscent of the one
reported case of human infection as well as disease caused by other neurotropic
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flaviviruses (e.g., WNV, JEV, and ZIKV) (96). Nevertheless, it is important to note
that the route of inoculation appears to influence disease outcome. For SCID
mice, which lack the ability to mount an adaptive immune response, inoculation
through either intracerebral, intraperitoneal, or intranasal routes leads to
paralysis by days 6, 11, and 12 days post-infection, respectively, and mortality by
days 9, 13, and 14, respectively. In contrast, immunocompetent NMRI mice are
paralyzed by days 6 and 12 when inoculated intracerebrally or intranasally,
respectively (death occurs by days 9 and 13, respectively) but do not succumb to
disease subsequent to intraperitoneal challenge (66). Finally, a separate
investigation found that infection of SCID and NMRI mice with
cyclophosphamide-induced immunodeficiency exhibited similar encephalitic
disease which, when coupled with positive staining for MODV antigen in neurons,
suggests that MODV may directly infect and damage neuronal tissue leading to
disease in lieu of immunopathology caused by inflammatory infiltrates (95).
More recent studies with MODV have used the virus as a comparative
model to better understand the unique features and subtle discrepancies which
determine the range of host infectivity, replication efficiency, and disease
outcome among various flaviviruses. For example, replacement of the prM-E
structural genes of MODV with homologous gene sequences from WNV
generates an infectious chimera that can still replicate in vertebrate (Vero) cells
but does not gain the ability to replicate in mosquito (C6/36) cells (52). Moreover,
it is interesting that the replication kinetics of both the wild-type and chimeric
MODV variants remain similar while wild-type WNV demonstrates a much less
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linear, more rapid, and higher-titer replicative strategy (Figure 2.7). Conversely,
the construction of viral recombinants containing either a DENV-2 or YFV
backbone but with prM-E genes from MODV yields an infectious virus that
replicates in both vertebrate and mosquito cell lines (97). Taken together, these
findings suggest that the inability of MODV to replicate in invertebrate cells is not
caused by a failure to infect susceptible cell lines but rather is limited by specific
intracellular host factors or post-entry events. Lastly, aside from exploring the
restricted capacity for MODV to infect invertebrate cells, alterations to tissue
tropism and immune subversion have been identified by additional studies in
which the genes encoding pr-M proteins or first 10 amino acids comprising the
NS5 protein, respectively, of MODV have replaced these components on a YFV
backbone. In the former study, it was found that the chimeric virus exhibited
properties of neuroinvasion that were absent from the wild-type strain of YFV
when SCID mice were infected by the intraperitoneal route (98). Recovery of
these chimeras from cell culture revealed N-linked glycosylation of the E protein,
a discovery which corroborates separate research demonstrating variable
neuroinvasion by distinct lineages of WNV with and without glycosylation motifs
(45). In the latter study, manipulating the upstream portion of YFV NS5 to match
that of MODV’s NS5 sequence abrogates the ability for YFV to antagonize IFN-I
signaling by binding to STAT2 transcription factors (99). Indeed, similar
investigations have been carried out to examine the non-coding genetic elements
in both the 5’ and 3’ UTRs of MODV and other flaviviruses, although the results
of these studies are not reviewed here (94, 100).
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Figure 8

Figure 2.7: Replication kinetics of WNV, wild-type MODV, and chimeric
MODV in Vero cells. Vero cells were inoculated at a multiplicity of infection of
0.1 with either wild-type WNV (closed circles), wild-type MODV (squares), or a
chimeric virus in which the prM and E structural proteins from a full-length MODV
infectious cDNA clone were replaced with the same structural genes from WNV
(diamonds). Modified from Saiyasombat et al., 2014 (52).
Typically, NKV flaviviruses present very little threat to general public
health. For MODV, only one case of human disease has been documented in
which a young boy developed aseptic meningitis after allegedly playing with a
wild mouse (101). Regular subclinical infection does not appear uncommon,
though, as antibodies against MODV have been recovered from humans in at
least one investigation (6). While there is no indication that MODV may become
an immediate concern, it is interesting to note that other flaviviruses (e.g., ZIKV)
had circulated for many decades before random mutations led to increased
virulence and pathogenesis in humans (102). Nevertheless, MODV offers an
appealing alternative for flaviviral research given its ease for access (BLS-2),
permissibility for laboratory culture and manipulation, and the ability to
recapitulate neurologic disease reminiscent of other, more virulent flaviviruses
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(64). Of all the NKVs characterized at present, MODV certainly has been the
most thoroughly examined and therefore offers the most complete background of
foundational knowledge to aid in the construction of novel research pursuits.
Pathogen Recognition and Antiviral Signaling
The outcome of any given viral infection is subject to a variety of nonmutually exclusive factors. In most cases, the route of viral inoculation, as well as
the titer (i.e., dosage) of viral exposure will dictate the resulting host pathology
(103). However, it has been demonstrated that the exact host species can
influence the outcome of clinical disease even when the parameters of viral
infection are experimentally standardized (95, 104). In any case, the dichotomy
between severe host pathology or disease resistance can essentially be
accredited to the precarious balance between the immune system’s ability to
restrict direct damage caused by viral replication and the propensity to inflict
collateral damage through a process termed immunopathology (105, 106).
Regardless of the above considerations, successful resolution (i.e.
clearance) of a viral infection in a vertebrate host begins with pathogen
recognition and downstream activation of the innate immune response. Although
often described as “non-specific,” surveilling cells of the innate response do, in
fact, recognize non-self antigens in the form of conserved, pathogen-associated
molecular patterns (PAMPs) indicative of invading microorganisms. Through the
use of the membrane-bound major histocompatibility complex I (MHC-I), all
nucleated cells possess the ability to present endogenous protein samples that
serve to provide insight into intracellular environment (107). Specialize cells such
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as CD8+ T lymphocytes (T cells) interact with protein samples displayed on
MHC-I to “taste” whether they constitute the material of foreign or self-origin. If T
cell receptors (TCRs) on CD8+ T cells recognize samples displayed on MHC-I as
non-self, the newly activated cytotoxic T cell (Tc) may induce apoptosis in the
bound cell through the release of membrane-degrading granzymes and perforins.
Importantly, however, is that this death signal is only delivered when signaling
from receptor-antigen complexes are accompanied by co-stimulation from either
antigen-presenting cells (APCs) or via the presence of signaling molecules
known as cytokines. Cytokines encompass a diverse group of small, secreted
proteins that facilitate communication, proliferation, and effector functions
between local and systemic cells during an active immune response. In the
context of the antiviral response, cytokine representatives of great importance
include the various interferons (IFNs), interleukins (ILs), and chemokines
(chemotactic cytokines; CCL or CXCLs).
Complementary to MHC-I presentation is the ability for some cells to
present extracellularly-acquired protein samples on major histocompatibility
complex II (MHC-II). These “professional” APCs include B lymphocytes (B cells)
as well as myeloid-derived macrophages and dendritic cells (DCs). Through
phagocytosis, pinocytosis, or receptor-mediated endocytosis, molecules
encountered in the extracellular environment are internalized and trafficked to
degradative endosomes wherein protein samples can be randomly selected for
display on membrane-bound MHC-II. When acting as roaming sentinel cells,
macrophages and dendritic cells that encounter antigen in the extracellular
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environment may migrate back to secondary lymphoid tissues to either activate
or “request clearance” from naïve CD4+ T cells. If deemed appropriate, T celldependent activation of these innate sentinels leads to the production of
cytokines that coordinate a systemic immune response (e.g., global upregulation
of MHC-I) (108). Similarly, B cells that encounter exogenous antigen
complementary to B cell receptor (BCR) immunoglobulins may internalize the
receptor-antigen complex for processing and presentation on MHC-II (109).
Subsequent T cell-dependent activation of B cells presenting in this manner
allows for the release of antibodies that neutralize extracellular pathogens or flag
them for destruction via phagocytosis.
Despite the perceived benefits of random molecular sampling and
presentation on MHC-I and II, these receptors are limited by their need to display
antigens of strictly protein origin. Toward this end, additional surveillance is
performed by PRRs to detected non-proteinaceous molecular PAMPs. Namely,
PRRs of particular interest include the membrane-bound and endosomal Toll-like
receptors (TLRs) as well as the cytosolic RIG-I-like receptors (RLRs). Expressed
principally on sentinel cells such as DCs and macrophages, TLRs that appear to
play a relevant role in viral sensing include TLRs 3, 7, 8 (humans only), and 9,
each of which is understood to emphasize detection of unique nucleic acid motifs
(dsRNA, ssRNA, or unmethylated CpG repeats in DNA, respectively) (110). In
contrast, viral sensing by RLRs utilizes ubiquitously expressed intracellular
receptors, which appear to be more or less moiety specific. The most wellstudied of these include the retinoic-acid-inducible gene I (RIG-I, after which the
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receptor family is named) and melanoma differentiation-associated gene 5
(MDA5); while RIG-I is believed to specialize in the detection of short, dsRNA
and ssRNA with 5’-triphosphate groups, MDA5 is speculated to provide
recognition of longer dsRNA. For all of these receptors (i.e. TLRs and RLRs
alike), stimulation secondary to PAMP binding results in either receptor
dimerization and activation of kinase activity or the exposure of second
messenger binding domains that trigger downstream signaling events. Through
the use of multiple adaptor proteins (e.g., TRAF3, TBK1, TANK, etc.),
phosphorylation cascades ultimately coalesce with the activation of transcription
factors such as the interferon-regulatory factors (IRFs) 3 and 7 as well as nuclear
factor-κB (NF-κB). Activation of these transcriptional regulators and subsequent
translocation into the nucleus then allows for the expression of antiviral signaling
molecules such as the type I interferons (IFN-I).
The use of IFNs and their related machinery to combat intracellular
pathogens is likely an ancient ancestral trait and is, in fact, conserved even at the
phylum level (111, 112). Once expressed within an infected cell, IFNs are
secreted as small peptides into the extracellular environment to elicit an antiviral
response through both autocrine and paracrine signaling (113). As of 2012, there
have been nine mammalian IFN-I subtypes identified: IFN-α (which includes 13
distinct isoforms), in addition to a single known representative of IFN-β, IFN-ε,
IFN-κ, IFN-ω, IFN-δ, IFN-τ, IFN-ν, IFN-ζ (114). Of these, IFN-α and IFN-β are the
most well understood in the context of viral infection. In brief, binding of type I
IFNs to the heterodimeric transmembrane receptors IFNAR1 and IFNAR2
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activates receptor-associated Janus kinases (JAK) Tyk2 and JAK1 (Figure 2.8).
Kinase activity from Tyk2 and JAK1 then auto- and transphosphorylate their
associated receptors to expose binding domains for the constitutively-expressed
signal transducer and activator of transcription (STAT) proteins. In the case of
type I IFN stimulus, phosphorylation of recruited STATs 1 and 2, along with
phosphorylated IRF9, generate the multimeric IFN-stimulated gene factor 3
(ISGF3) transcriptional complex. Canonical activation of ISGF3 following the
aforementioned transduction pathway is known to regulate the expression of
interferon-stimulated genes (ISGs) downstream of IFN-stimulated response
element (ISRE) promoters. Some examples of ISGs expressed during the
antiviral response include the intrinsic effectors proteins ISG15, 2’5’-OAS, PKR,
and Mx; however, over 100 unique ISGs have been characterized and
demonstrated to participate in various aspects of cellular defense or interference
of the viral replication cycle (the eponym for which IFNs are named) (115).
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Figure 9

Figure 2.8: Simplified schematic demonstrating the canonical signaling
pathways of types I through III interferons (IFN). Binding of type I (primarily
IFN-α/β) and type III (IFN-λ) IFNs with their cognate receptors leads to receptor
dimerization, auto- and transphosphorylation of TYK2 and JAK1, phosphorylation
and heterodimerization of STATs 1 and 2, the formation of the ISGF3 complex
with IRF9, and translocation of the complex into the nucleus to induce expression
of IFN-stimulated genes (ISGs) downstream of the IFN-stimulated response
element (IRES). Activation of type II (IFN-γ) IFN system is similar; however, two
additional membrane-bound receptor chains lead to the auto- and
transphosphorylation of JAKs 1 and 2 followed by the formation of a STAT1
homodimer. The gamma-interferon activation factor (GAF) complex then
translocates to the nuclear whereby antiviral genes (among others) can be
expressed downstream of a gamma-interferon activation site (GAS). Modified
from Hoffmann et al., 2015 (116).
As alluded to above, additional interferons exist that are functionally and
structurally separate from the type I IFNs. These include the type III IFNs (IFNλ1, IFN-λ2, and IFN-λ3, previously denoted as IL-29, IL-28A, and IL-28B,
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respectively) as well as a singular type II IFN (IFN-γ). Interestingly, all three types
of IFNs share a conserved helical-bundle architecture and are thus grouped
together in class II alpha-helical cytokine family along with representatives such
as IL-10 and IL-22 (117). Despite commonalities in their larger secondary
structure, however, amino-acid identity and structural homology between specific
IFNs of all types exhibit a range from 20 to 100% (114). This variability is
reflected in the functional aspects for which each of the IFNs contributes to the
induction of an antiviral response, as well as for additional roles that some IFNs
serve. Like the type I IFNS, type III IFN signaling following viral stimulus utilizes
JAK1 and Tyk2 to activate the ISGF3 transcriptional regulator and express ISGs
downstream of the ISRE promoter region. Contributing to their functional
separation from type I IFNs, however, is the use of the receptors IFNLR1 and
IL10RB to initiate signal transduction; this suggests that type III IFNs may
contribute to antiviral defenses in an independent and/or synergistic manner to
type I IFNs. While IL10RB is expressed on a variety of diverse mammalian cells,
IFNLR1 expression is minimal or lacking on macrophages and some lymphoidderived effector cells (114). Type II IFNs likewise utilize distinct membrane-bound
receptors (IFNGR1 and 2) to elicit intracellular signaling; unique, however, is the
activation of JAKs 1 and 2 to induce the formation of a dual-phosphorylated
STAT1 homodimer. Phospho-STAT1 homodimers translocate to the nucleus
upon where they bind to a regulator promoter known as the gamma activation
site (GAS). Genes expressed downstream of GAS elements include an
assortment of molecules, some of which participate directly in the antiviral
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response (e.g., ISGs), and some of which appear to coordinate actions between
effector cells (see more below). Curiously, whereas a large variety of cell types
may produce IFN-β, secretion of various IFN-α isoforms appears to be more
selectively regulated by leukocytes such as macrophages and plasmacytoid
dendritic cells (pDCs) (113). IFN-γ expression is similarly restricted to immune
effectors cells, in this case, TH cells, macrophages, and natural killer cells (NK
cells; innate effector cells of lymphoid origin). While it is known that experimental
infection with an assortment of viruses leads to the expression of IFN-λ1, 2, or 3
in epithelial and monocyte-derived DCs, further research is still required to fully
elucidate the origin and influence of these IFNs as they pertain to the antiviral
response (118).
As a viral infection progresses beyond the initial stages of pathogen
recognition and control, the innate immune response must ultimately attempt to
coordinate the adaptive arm of the immune system. Initiation of this highlyspecific response is accomplished in part by the presentation of captured
antigens displayed on MHC II to naïve CD4+ T cells residing in germinal centers
of secondary lymphatic tissues. Along with the aid of upregulated co-stimulatory
molecules expressed on the surface of both APCs and T cells (e.g., CD40 and
CD40L, respectively), complete activation of naïve CD4+ T cells results in the
production of T helper cell precursors (TH0) that undergo proliferative clonal
expansion facilitated by autocrine signaling of IL-2. Once activated, the resident
cytokine milieu influences a “polarization” (i.e. differentiation) of T H0 cells toward
population phenotypes that favor either cell-mediated or humoral immunity (119).
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Historically denoted as “type 1 immunity,” cell-mediated immunity is chiefly
characterized by the production of cytokines, which stimulate inflammation and
further boost phagocytic activity. TH cells representing cell-mediated immunity
(referred to as TH1 cells) are driven to differentiation by expression of the
transcription factor T-bet and secrete cytokines, which include, but are not limited
to, IL-2, IL-12, and IFN-γ. Further, TH1 cells are characterized by a profile of
chemokine receptors that facilitate the migration of these cells to areas of active
inflammation (e.g., CXCR3 and CCR5) (120). In contrast, humoral (i.e. “type 2”)
immunity can be identified by the production of cytokines IL-4, -5, and -13 by T H2
cell subtypes expressing high quantities of the transcription factor GATA-3.
Among various other functions, these cytokines lead to increased B cell
activation (including clonal expansion and affinity maturation), antibody
production by B cell-differentiated plasma cells, and antibody class-switching.
Chemokine receptors expressed on TH2 subtypes include, but are not limited to,
CCR3, -4, and -8.
In the context of viral infection, it is believed that the balance between T H
phenotypes of the adaptive response, as well as the timing of the transition
between the innate and adaptive responses, will likely play a significant role in
the clinical outcome of disease (120). For this reason, it is imperative that all cells
participating in the immune response be able to rapidly and appropriately
respond given the origin of antigen stimulus so as to harmonize an amalgamation
of the immune system as a whole. Further, it is crucial that both effector and noneffector cells possess the ability to mollify and suppress fulminant inflammation
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prior to the development of immunopathology that may result during an overlyrobust or chronically-sustained antiviral response. In the intracellular
environment, this is accomplished by the upregulation of protein mediators that
act to regulate activated signaling cascades. For example, suppressors of
cytokine signaling (SOCS) proteins are encoded downstream of ISGs and thus
are expressed subsequent to STAT-mediated transcription; once expressed,
SOCS proteins interfere with the functionality of JAK proteins in a manner that
represents a negative feedback loop (112). Beyond this ability for individual cells
to quell internal signaling cascades, there exists evidence for a macrophage
phenotype separate from the previous two, which aids dampen the inflammatory
response (121). Finally, cells participating in the immune response receive
external instruction by an additional subset of T cells known as regulatory T cells
(TReg). TReg cells are typified by the expression of the forkhead box P3 (FOXP3)
transcription factor and the secretion of immunomodulatory cytokines such as IL10 and transforming growth factor-β (TGFβ). Although all of the functional
mechanisms of TReg cell-induced immunosuppression have yet to be fully
elucidated, it is now clear that these cells utilize multiple strategies to direct
immune homeostasis both during and immediately following the antiviral
response (122). However, as described in the following section, viral interference
of these suppressive mechanisms may be one of many strategies employed by
viruses to subvert a successful immune response.
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Flavivirus Immune Subversion and Host Pathology
As was very briefly described above, the vertebrate immune response has
evolved to offer a complex and tightly regulated orchestration of cells proficient in
detecting, neutralizing, and degrading viral pathogens. In light of this highlyeffective protective system, but driven by the obligation to hijack cellular
machinery to undergo replication, viruses have likewise evolved a slew of
strategic mechanisms to overcome host recognition and removal. This paradigm
is no less accurate for clinically relevant representatives of the Flavivirus genus,
all of which act to suppress the innate immune response in some form or another
(123).
Upon initial infection and cellular entry, most viral pathogens are
recognized by PRRs expressed either in endosomes (TLRs) or in the cytosol
(RLRs). For many of the well-studied flaviviruses, it appears that RLRs play a
more pivotal role than TLRs, a premise corroborated by the finding that RIG-Ideficient cells infected with JEV fail to express type I IFNs indicative of the early
antiviral response (110, 124). It appears that interactions like these are variable,
however, as IRF3 activation is not diminished but simply delayed during infection
of RIG-I null mouse fibroblasts with the New York strain of WNV (WNV-NY)
(125). Indeed, the inclusion of a 5’ methyl cap on flaviviral RNA presumably
prevents immediate recognition by RIG-I sensors and further disguises the viral
genome as a potential host transcript. Additionally, though, delayed recognition
of flaviviral nucleic acids and replication intermediates by cytosolic PRRs is
further preserved by the formation of vesicle packets (VPs) created by virus-
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induced remodeling of the ER membrane (125). Not only do these membrane
invaginations act to shield viral components from detection, but a redistribution of
cholesterol within the cell to create VPs may abrogate cellular signaling cascades
(e.g., JAK/STAT) that initiate in lipid microdomains at the cell’s surface (26, 36).
Finally, some flaviviruses (e.g., WNV and DENV) may instigate an upregulation
in the expression of MHC-I complexes, and antigen processing, a strategy that
inhibits the cytotoxic protectivity of surveilling NK cells (126).
As is the case for many simplified RNA viruses, most flaviviral proteins
(both structural and nonstructural) serve the dual role of aiding in replication as
well as antagonizing the antiviral immune response. In particular, the NS5
protein, whose primary function is to act as an RNA-dependent RNA polymerase
(RdRp), has been implicated in a variety of distinct IFN-suppressive roles
depending on the exact host cell and flavivirus under investigation. Examples of
such events include the proteasomal degradation of STAT2 proteins by DENV
and ZIKV NS5, suppression of ISG transcription by NS5 from YFV and
Spondweni (SPOV; a close relative of ZIKV), activation of protein tyrosine
phosphatases by JEV NS5, or suppression of IFNAR1 maturation and membrane
trafficking by WNV, TBEV, and LGTV NS5 (99, 127-130). NS4B is another
nonstructural protein required for viral replication but believed (in the case of
DENV infection) to downregulate RNA interference machinery (RNAi) used by
host cells to degrade dsRNA (131). Nonstructural proteins NS2A and NS4A, both
necessary for viral replication and packaging, impair IFN signaling by inhibiting
STAT1 phosphorylation and translocation to the nucleus. Even the 3’ UTR of
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many flaviviruses participates in immune antagonism through the generation of a
subgenomic flaviviral RNA (sfRNA) produced during the attempted degradation
of viral transcripts by the host exoribonuclease XRN1 (132). As a consequence,
not only do nascent copies of the sfRNA then directly inhibit further XRN1
activity, but sfRNAs additionally act to suppress the type I IFN response through
mechanisms that remain to be completely understood.
Although it is highly unusual for any virus to encode and secrete viral
proteins into the extracellular environment, flaviviral NS1 has been identified as a
soluble, hexameric glycoprotein circulating in the blood or accumulating in the
dimeric form on the surface of infected cell membranes (133, 134). Within the
cell, NS1 performs a vital role in the replication cycle by acting as a cofactor for
the RdRp activity of NS5 (135). There is evidence to suggest, however, that
secreted NS1 circulating in the blood of vertebrate hosts may contribute to an
increase in viral uptake for invertebrate vectors such as mosquitoes (136).
Furthermore, it has been shown that soluble NS1 may bind to and inactivate
components of the complement system (a branch of the innate immune response
that utilizes soluble proteins to, among other functions, opsonize circulating viral
pathogens) (133, 137). Indeed, crosstalk between complement components
(e.g., C1q) and secreted NS1 has provided the impetus for further investigation
as to whether abnormally high levels of liver-derived acute-phase proteins during
infection with DENV may contribute to the vascular leak syndromes associated
with instances of hemorrhage disease (138).
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In regard to the virion itself, alterations in the structure and antigenicity of
the E protein caused by low-fidelity transcription of the RdRp may influence
successful immune evasion as well as tissue tropism (i.e. preference) and
pathogenic virulence (126). As base pair mutations in the genome of progeny
virus accumulate, amino acid variations may give way to the production of
escape mutants that circumvent neutralizing antibodies in a manner similar to
seasonal strains of influenza virus (139). In contrast, as has been demonstrated
with WNV, differential glycosylation of the E protein by various host cell and
tissue types may significantly alter neuroinvasiveness and neurovirulence even
when variations in nucleotide and amino acid sequences remain minimal (140).
Finally, there exists a prominent concern for the ability of cross-reactive
antibodies (generated either during previous flaviviral infection or against the
exposed epitopes of immature virions) to promote increased viral replication
when poorly neutralizing IgG facilities the uptake of virions into innate effector
cells expressing Fc receptors (141, 142). While not yet fully understood, infection
of monocytes, DCs, and macrophages in this manner could lead to an
overproduction of proinflammatory cytokines in a process called antibodydependent enhancement (ADE; Figure 2.3). Likewise, dysregulation during
infection of these important immune cells may skew the timely secretion of
immunosuppressive cytokines like IL-10, which help to control collateral damage
inflicted by an unchecked host antiviral response (126, 143).
In any case, there is sufficient justification to postulate that the exact
mechanisms of flaviviral immune evasion and subsequent virulence culminate as
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the result of many subtle but significant interactions between polymorphic
phenotypes in both the host as well as the infecting virus (123, 144, 145).
Fortunately, infection with most flaviviral isolates results in relatively mild, flu-like
signs and symptoms that spontaneously self-resolve in one to two weeks. In the
event that immune subversion or antagonism is sufficient to induce severe
clinical disease, however, flaviviral pathologies can be broadly divided into those
which cause hemorrhagic fevers, hepatic or neurologic disease, and as of late,
defects in fetal development. For hemorrhagic fevers, of which DENV is the most
prominent and well-studied etiologic flaviviral agent, disease is largely
immunopathogenic and results primarily from a loss in vascular integrity
secondary to excessive activation of the complement system, cross-reactive T H
cells, and proinflammatory DCs and macrophages (the latter of which act as the
primary targets of DENV replication) (126, 146). Although manifestations of
disease caused by DENV were previously categorized as either dengue fever
(DF), dengue hemorrhagic fever (DHF; grades I-IV), or dengue shock syndrome
(DSS; specific to grades III and IV of DHF), classification was revised by the
WHO in 2009 due to the clinical and physiologic overlap between categories; as
such, current diagnoses include only “dengue with or without warning signs”
(e.g., abdominal pain, persistent vomiting, mucosal bleeding, lethargy, mild
hepatomegaly and increased hematocrit concurrent with thrombocytopenia) or
“severe dengue” (e.g., plasma leakage leading to hypovolemic shock, fluid
accumulation with respiratory distress and severe organ involvement) (147).
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In a similar fashion, disease associated with representatives such as
WNV, JEV and TBEV appears to be induced immunopathologically; the
difference in clinical presentation, therefore, results from a predilection of each
virus toward neuronal cells in the brainstem and spinal cord (148, 149). As viral
replication in the central nervous system (CNS) ensues, expression of
proinflammatory cytokines by neurons and activated glial cells encourages the
recruitment of cytotoxic effectors such as neutrophils and T H1 cells, both of which
secrete mediators (e.g., TNFα) that lead to collateral damage of neurons and
supportive cells in the local environment (148, 150). Ongoing studies with ZIKV
have likewise indicated neuronal and glial tropism during acute infection;
however, select isolates of ZIKV differently infect a broad range of tissues,
including stem and progenitor cells in the CNS and retina, each of which may
contribute to significant birth defects when mothers are exposed during early
pregnancy (151, 152). Further, the detection of infectious virus shed in the
semen of adult males for up to three months following exposure has established
ZIKV as the only flavivirus implicated in direct human-to-human transmission
(153).
While disease caused by YFV may include hemorrhagic shock syndromes
similar to those induced by DENV, YFV is uniquely but significantly hepatotropic
(154). As such, liver dysfunction over the course of infection leads to a jaundiced
appearance in patients, a clinical feature from which the “yellow fever” virus
derives its name. Further, it is curious to note the relative lack of inflammatory
infiltrates (e.g., monocytes) in hepatic tissues analyzed from infected individuals
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(155). Although this finding provides evidence to suggest that the observed
damage to hepatocytes is, therefore, a consequence of direct, viral cytopathic
effect (CPE), other reports highlight the apoptotic role of secreted TGF-β, a
mechanism which may indicate that clinical disease caused by YFV is likewise
primarily immunopathologic in origin (156).
Vaccination and Treatment Against Flaviviral Disease
Unlike most bacterial infections, disease caused by the majority of viral
pathogens cannot be treated with the use of post-exposure therapeutics. This
reality is no less applicable for the flaviviruses given that there are currently no
licensed antiviral drugs that may be called upon to alleviate severe clinical
illness. It is, therefore, essential that preventative practices shape the foundation
upon which humans (and their animal companions) attempt to avoid morbidity
and premature death caused by these viruses. Indeed, efforts to control vector
populations and exposure have arguably provided the most effective avenue for
thwarting infection; however, many scenarios exist in which these practices are
infeasible or simply insufficient. These shortcomings are further compounded by
the range expansion of invertebrate vectors into historically non-endemic habitats
(see Flaviviral Ecology and Distribution). Coupled with the ever-increasing
prevalence and frequency of global travel, an upraise in the incidence of flaviviral
infection and disease has led to a subsequent urgency to continue pursuing
vaccine development and implementation.
Astoundingly, the first successful arboviral vaccine occurred during an era
when infectious disease research as a whole, was still very much in its infancy.
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Through continuing the promising work of Louis Pasteur, a French isolate of YFV
was passaged over 200 times in murine hosts, producing a distinct viral
phenotype that exhibited substantial attenuation compared to the wild-type
derivative (157). Inoculation with this live-attenuated virus provided sufficient
protection to significantly decrease the global incidence of YF disease throughout
the 1940s and 50s, prompting Collins et al. to label the vaccine as “the original
breakthrough” against flaviviral disease (10). While this particular vaccine was
eventually discontinued due to an unforeseen neurotropism acquired during
serial passaging (and subsequent vaccine-induced encephalitis in children), it
was immediately superseded by a comparable live-attenuated strain originally
isolated from an infected patient (Mr. Asibi) in Ghana. Referred to now as the
17D vaccine strain, the Asibi vaccine is used worldwide to produce lifelong
immunity by inducing neutralizing antibodies in 99% of adults and 90% of
children (158). Further, aside from representing one of the oldest vaccines
administered to date, the genomic architecture of the 17D strain has been utilized
to create a “flexible backbone” in which structural genes from other flaviviruses
can be exchanged with those of YFV to produce a recombinant virus capable of
safely exposing patients to antigens from representatives that resist immunity
elicited by traditional attenuation.
In addition to YFV, a successful live-attenuated vaccine has been
developed for JEV (strain SA14-14-2). Unlike 17D, however, which is selectively
administered pro re nata (e.g., military or research personnel or during times of
endemic outbreaks), JEV SA14-14-2 is included in a series of routine pediatric
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immunizations for children living in most regions of China (81). Widespread
administration of this immunogenic vaccine has been paramount in the
prevention of flaviviral encephalopathies induced not only by JEV but potentially
by other neurotropic flaviviruses in light of the few studies which have observed
protective immunity through cross-reactive neutralizing antibodies (159, 160). At
present, the armamentarium against JEV includes a total of three vaccine
formulations: the live-attenuated strain referenced above, an inactivated vaccine
derived from one of four viral strains, or a (live-attenuated) 17D chimera in which
the prM and E genes of YFV have been replaced by those of JEV (81).
Unlike YFV and JEV, flaviviruses such as WNV, ZIKV, and until very
recently, DENV have all eluded traditional approaches to effective vaccination in
human populations. For WNV, several vaccine candidates have utilized novel
molecular technologies (e.g., DNA plasmids) to provide formulations that appear
protective in rodent and equine models (161). As well, ongoing work with a 17D
candidate (ChimeraVax) has elicited high titers of WNV-specific antibodies and is
currently under investigation in Phase II clinical trials (162). Despite the
promising outlook, factors such as long-term vaccine efficacy, stability, patient
tolerability (i.e. allergenicity), and cost of production all contribute to the paucity
of a WNV vaccine currently fit for public distribution. Similar obstacles have
arisen in the attempt to develop a vaccine against DENV; however, researchers
must also contend with the fact that DENV comprises four antigenically distinct
serotypes that cocirculate in endemic regions (10). While some evidence
suggests that infection with one serotype may confer transient protective
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immunity against symptomatic infection by diverse serotypes, contrasting data
has indicated that cross-reactive, non-neutralizing antibodies may actually
enhance disease during secondary infections (i.e. ADE) (163). The latter
recognition has prompted the desire to construct a formulation that offers
protection against all serotypes, given the concern that vaccination against only
one may predispose individuals to develop more severe disease upon
subsequent natural infection. This objective has proven difficult as evidenced by
the late Phase III clinical trials of Dengvaxia (a 17D derivative) in 2011 when
recipients demonstrated variable protectivity against each serotype and an
alleged increased of vaccine-induced dengue fever in certain Asian
demographics (164, 165). Fortunately, successive iterations of Dengvaxia have
remedied any apparent adverse reactions and, as of 2019, was approved by the
FDA as the first licensed vaccine for the prevention of DENV in endemic regions
(166).
While there are no vaccines that have been approved for ZIKV at the time
of writing this review, there exist multiple diverse and promising candidates
currently in various phases of development and clinical testing. Surprisingly, both
chemically-inactivated and live-attenuated approaches have demonstrated
protectivity against lethal challenge in rodent models as well as non-human
primates (167-169). Amazingly, there is even evidence to suggest that adenoviral
vectors expressing ZIKV E proteins fused to fibritin (a bacteriophage structural
protein) may protect mouse pups against viral challenge following birth (170).
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Induced immunity to this extend marks enormous success given the ability of
ZIKV to transverse placental barriers and cause disease in developing fetuses.
In terms of protection against pan-flaviviral threats, there is reason to
believe that increasingly novel vaccination methodologies will continue to provide
support in the battle against disease. For example, the use of lipid nanoparticles
to deliver mRNA transcripts encoding the prM and E proteins have induced
neutralizing antibodies for ZIKV in addition to multiple tick-borne flaviviruses such
as LGTV and Powassan virus (POWV) (171, 172). Broadening the scope of
attack even further, some researchers have investigated the potential for
reducing the severity of clinical disease by vaccinating against mosquito salivary
proteins that appear to contribute to host immune suppression during flaviviral
infection (173). Indeed, Bidet et al. have further postulated in recent studies that
emulating “immune signatures” of natural exposure (through the use of targeted
adjuvants) may provide a lucrative avenue in an attempt to strengthen the
immunogenic response elicited by subunit vaccines (174). Lastly, there is still
hope for anti-flaviviral therapeutics, which may provide an avenue for postexposure intervention. To this end, ongoing research is exploring the potential for
producing monoclonal antibodies (mAb) in plants, which can be glycoengineered
to circumvent the induction of ADE when poorly neutralizing antibodies from
cross-reactive flaviviruses interact (175). Likewise, extensive libraries of
previously FDA-approved small molecules are continuously tested for
repurposing as competitive or allosteric inhibitors of viral enzymes (176-179).
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As a closing note, it is important to consider that the successful
development of vaccines and therapeutics does not in itself guarantee a
widespread decrease in disease burden. Rather, interventions must also be
distributed and administered to the populations that need them most, an
unfortunate conundrum given that the majority of highly at-risk individuals reside
in impoverished areas with poor infrastructure (180). This issue is particularly
problematic for live-attenuated vaccines, which typically demand higher
production costs and must abide by cold-chain transportation. Indeed, the
paradigm of ineffectual vaccine distribution was highlighted in 2003 by an
estimate suggesting that nearly 3 million children succumb to preventable viral
disease annually as a consequence of poor vaccine accessibility or
implementation (181). Although this realization has sparked the construction of
organizations such as the Global Alliance for Vaccines and Immunization (GAVI),
factors such as population growth (in both affluent and impoverished
demographics), frequent international travel, human encroachment in diverse
habitats, and changes to global climate have all contributed to the continued
need for advancements in the ongoing battle against viral disease.
The Use of Animal Models in Scientific Research
The use of non-human organisms to aid scientific research can be traced
back as early as the 6th century BCE when canines were used to demonstrate
that the brain is responsible for processing sensory input and coordinating
complex behaviors (182). From this time forward, researchers have utilized a
broad array of plant, bacterial, fungal, and animal models to better understand
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the biotic world from which we are all derived. Eventually, “model organisms”
were established that provided researchers with representatives that were wellstudied, cost-effective to acquire and maintain, and easy to handle or manipulate
(183). Examples of these organisms include the small, flowering thale cress
(Arabidopsis thaliana), the bacterium Escherichia coli, the unicellular yeast
Saccharomyces cerevisiae, eukaryotic invertebrates such as the nematode
(Caenorhabditis elegans) and the fruit fly (Drosophila melanogaster), and the
common house mouse, Mus musculus. Decades of research with these
organisms have cast the foundation for our current knowledge of core disciplines
such as genetics, developmental biology, anatomy and physiology, aging,
metabolism, and infectious disease, among many others.
In particular, rodent models have served a pivotal role in pioneering the
field for biomedical research (184). Although recognizably divergent from
humans, homologous genes and conserved signaling pathways can be studied in
rodents to better understand the functions and failures of these systems in
humans. Likewise, research with these models in the context of infectious
disease has been instrumental in bolstering the scientific community’s
understanding of disease pathology, therapeutic targeting and treatment, and
vaccine development and testing. Evidence for the importance of rodent models
becomes increasingly apparent when considering the investigation of zoonoses,
diseases that are acquired either directly or indirectly from non-human hosts
(185). Accounting for over 60% of emerging infectious diseases (EIDs)
worldwide, zoonoses can be found on nearly every continent and infect hundreds
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of millions of individuals annually (186, 187). Unfortunately, despite advances in
scientific research and medical practice, there is little indication to believe that
infection incidence from zoonoses will decline given the environmental changes
and anthropogenic practices that encourage peridomestic arrangement with the
animals that carry infectious disease (188). Due to this prevalent and on-going
threat to global public health, rodent models are therefore employed to study
zoonotic disease either directly, as is the case for rodent-borne diseases (e.g.,
hantaviruses), or indirectly, as when rodent models are used to recapitulate
human-like disease (e.g., guinea pigs infected with Lujo arenavirus) (189, 190).
The potential for genetic manipulation and production for transgenic
variants have also promoted Mus musculus (or M. domesticus) and, to a less
extent, the brown rat (Rattus rattus or R. norvegicus) as the primary rodent
models of choice (191, 192) for research in immunology and related fields. Over
time, as the use of these models grew, litters were selectively inbred to produce
colonies that expressed less genetic variation and, in some cases, exhibited
peculiar phenotypes ideal for testing experimental hypotheses (e.g., severe
combined immunodeficiency (SCID) mice used to examine the adaptive immune
response). Currently, nearly 50,000 unique strains of M. musculus and around
2,900 strains of R. norvegicus have been identified and registered with the
Mouse and Rat Genome Databases, respectively (193, 194). Distinct phenotypes
from various strains have provided models for research on, but not limited to,
behavior, genetic heredity, aberrant metabolic function and disorders (e.g.,
nutrient acquisition and obesity), aging, cancer, and neurologic disease (182). It
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is important to note, however, that while selective inbreeding may reduce genetic
variation, thereby allowing for high experimental reproducibility along with a
reduction in background error, the caveat may be that results from these studies
cannot be functionally extrapolated to genetically heterogeneous populations
(e.g., animals in nature) (195, 196). For this reason, among others, some
researchers have taken up the use of non-traditional rodent models as a strategy
to approach familiar questions from a new point of view.
Deer Mice
Despite their colloquial nomenclature, deer mice (genus Peromyscus)
represent a phylogenetically distinct group of rodents situated within the family
Cricetidae (subfamily Sigmodontinae) along with voles and Old World hamsters
(197). It is likely that these small (8 to 10 cm, 20-30 g) rodents were initially
denoted as “mice” given their similar appearance to members of the Muridae
family (198). In reality, however, peromyscines diverged from Mus and other
murid representatives nearly 25 million years ago as determined through the
comparative sequencing of four highly-conserved nuclear genes totaling
approximately 6,400 base pairs (Figure 2.9) (197). This stands in contrast to the
divergence between Peromyscus and the cricetids, which occurred only 16-19
million years ago when using the same phylogenetic approach (197). Currently,
56 biologically-distinct species have been recognized, including the prototypic
deer mouse (P. maniculatus) as well as the equally renown white-footed mouse
(P. leucopus) (199). Representatives of this genus can be found in virtually every
habitat of North America, extending from Canada and Alaska to the Southern
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border of Panama, thereby making them the most abundant mammal in the
region (199-201).

Figure 10

Figure 2.9: Simplified phylogeny representing divergence of the Muridae
and Cricetidae rodent families approximately 25 million years ago (199).
Reconstruction of this simplified phylogram from data originally published by
Steppan et al. (197).
Use of deer mice in the laboratory setting is not entirely novel, as these
rodents have been implemented for research on animal ecology, behavior,
reproduction, aging, evolution, and physiological adaptation as far back as the
early 1900s (199, 202-204). Despite this, commercially-available reagents (e.g.,
antibodies) and public-access databases skewed toward a historical use of Mus
and Rattus spp. has led to a paucity of data and resources for molecular and
biomedical research with Peromyscus (205). On the other hand, recent decades
have witnessed a renewed interest in the use of deer mice as alternative models
for research in a variety of both homeostatic and infectious diseases (188, 204,
205). In part, it is intriguing that some species may exceed the average lifespan
of M. musculus by nearly four times despite having a roughly equivalent body
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mass (205). Nevertheless, colonies of Peromyscus must be maintained and
utilized in relatively outbred stocks as compared to many inbred strains of Mus
and Rattus (204). Granted, the purpose of implementing inbred strains for
laboratory investigations posits that a decrease in genetic diversity should
mitigate extraneous error and increase the reproducibility of experimental results;
however, the caveat to this approach is that experimental findings may not be
truly reflective of the biological outcomes in a natural setting where genetic
diversity provides the foundation for adaptive evolution (205). Likewise, selective
inbreeding may lead to the unintentional loss of important gene variants, which
are polymorphic in nature but under no selective pressure to be maintained
under laboratory husbandry (204-206). Thus, it is paramount to select an animal
model that sufficiently reflects the inherent genetic diversity among species
populations while still minimizing background error due to differences in
individual genomes. This is especially true of investigations which hope to
extrapolate data from research with animal models for use in human studies, for
which deer mice may offer a novel approach.
In the context of infectious disease, however, perhaps the most enticing
aspect for the use of peromyscines is their ability to host a variety of virulent
pathogens without any apparent disease or decrease in fitness (188). In
particular, the 1993 endemic outbreak of Sin Nombre hantavirus (SNV) in the
Four Corners region has sparked curiosity for the mechanisms which allow deer
mice to serve as reservoirs for agents that otherwise lead to debilitating illness in
humans (see more on reservoirs below) (207). Apart from SNV, deer mice have
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been implicated as hosts for additional viruses such as POWV and deer tick virus
(DTV), MODV, and Sal Vieja virus (SVV) (64, 208, 209). Moreover, a significant
number of bacterial pathogens have been isolated from deer mice such as
Anaplasma phagocytophilum, Ehrlichia muris, Coxiella burnetii, Bartonella spp.,
and various species of Borrelia, including B. burgdorferi, the causative agent of
Lyme disease (210-214). Although debated, Peromyscus spp. have even been
suggested as important reservoirs for the enzootic maintenance of plague
(caused by the bacteria Yersinia pestis) within the United States (215, 216).
Finally, there are a number of medically-relevant protozoan parasites that have
been isolated from deer mice, including Babesia microti, Schistosomatium
douthitti, and Trypanosoma spp., the causative agent of African sleeping
sickness (217-219). Indeed, the ability for deer mice to host such a broad array of
pathogens without succumbing to disease begs the question of what molecular
underpinnings can be discovered by studying these immunologically tolerant
rodents.
Syrian Golden Hamsters
Like the deer mouse, Syrian golden hamsters (Mesocricetus auratus) are
taxonomically-nested within the Cricetidae family of rodents having diverged from
murids approximately 25 million years ago (Figure 2.9) (197). Unlike the former,
golden hamsters have a lifespan of only 3 to 4 years in captivity and grow
comparatively larger than peromyscines, reaching lengths up to 18 cm with an
approximate range in body mass from 110 to 120 g. Moreover, wild golden
hamsters are far less ubiquitous than deer mice and have, in fact, been
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registered as vulnerable by the International Union for Conservation of Nature
(IUCN) due to habitat loss within their limited geographic range northern Syria
and southern Turkey (220). While the exact ecology and distribution of M.
auratus have not been entirely elucidated, it is understood that nearly all of the
individuals presently kept as pets or used in laboratory research are descended
from a single litter of only five siblings bred in 1930 (221). Following field
research conducted near Aleppo in 1997 through 1999, a total of 19 additional
individuals were recovered and used to supplement breeding stocks housed in
Germany before dissemination across the globe for various research pursuits
(222).
Research with golden hamsters shares a similar history as deer mice in
that their use in the laboratory setting is not entirely novel but has been restricted
by a lack of commercially-available reagents and available data in public
repositories. Nevertheless, early studies with these rodents utilized unique
aspects of their physiology and behavior to explore aspects of rodent
domestication, circadian rhythm, hibernation, and cancer. (223-227). Intriguingly,
many studies have used golden hamsters as models for the development of
dental caries, for which they appear to be naturally susceptible (228-230). Lastly,
the extremely short gestation period of golden hamsters (roughly 16 days) has
provided the impetus to further investigate the reproductive behavior and
physiology of these rodents with questions ranging from how food intake is
regulated during estrus to how social stress impacts a developing corpus luteum
(231-233).
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Indeed, golden hamsters have become yet another increasingly attractive
rodent model for studying infectious disease. In contrast to deer mice, however,
which offer the appeal of a model system that can tolerate infection by a variety
of diverse pathogens, golden hamsters are utilized given their ability to
recapitulate human-like illness (234). Infection models such as these ideally
mimic not only the clinical signs of disease but are also reminiscent of the
molecular (i.e. immune) response to pathogen exposure, as witnessed in
humans that become infected. Further, while these outcomes can sometimes be
achieved in Mus models with the aid of immunosuppressants or genetic
manipulation (e.g., ZIKV infection of STAT2 knockout mice), it is preferable to
investigate the immune response in the absence of these modulations to better
understand the interactions between pathogen and host under a more natural
context (235). In light of this, viral infection models using golden hamsters
include, but are not limited to, viral hemorrhagic fevers induced by Ebola viruses,
arenaviruses, and viscerotropic flaviviruses, cardiopulmonary syndromes such as
those elicited by hantaviruses, and encephalopathies caused by neurotropic
flaviviruses (96, 236-240). In regard to bacteria, experimental infection with
Leptospira interrogans offers an informative model to better understand the
cytokine profile and subsequent immune response following the development of
leptospirosis (a concern for both humans as well as wild and domestic animals)
(241). Finally, golden hamsters as models for infectious disease are perhaps
most well-renowned for their application in the study of parasitic eukaryotes such
as Leishmania (trypanosomes) and Taenia (tapeworms), both of which have
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eluded the use of more traditional rodent models (242-244). Due to their
susceptibility toward infection and disease, Syrian golden hamsters may,
therefore, offer an innovative approach for comparative studies aiming to
elucidate more clearly aspects of the immune response that result in host
pathologies.
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ABOUT THE ANTIVIRAL RESPONSE IN A
RESERVOIR MODEL OF ACUTE
FLAVIVIRAL INFECTION
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Abstract
To better understand the clinical outcomes of viral disease, it is necessary
to elucidate the interactions that take place between a virus and its host. In
particular, important clues may be gleaned from investigating the acute phase of
infection to better understand the early events which shape the subsequent
immune response and influence the long-term outcome of exposure (i.e. viral
clearance, persistence, or host death). In this study, we utilize the deer mouse
(Peromyscus maniculatus) to explore aspects of the innate immune response
during infection with a rodent-borne flavivirus. As Modoc virus (MODV) has only
ever been isolated from peromyscines in the wild, it is presumed that these
rodents act as the primary reservoir hosts. Deer mice in this study were
intraperitoneally challenged with MODV M544 and serially euthanized in order to
collect tissue samples from the kidneys, spleen, liver, and brain over a 10-day
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experimental period. Cardiac exsanguinations and bladder contents were
additionally collected at the time of necropsy. Quantifiable levels of MODV RNA
could be detected by RT-qPCR from all tissues and fluids at 24 hours postinfection and persisted throughout the entire duration of the experiment.
Infectious virus could be recovered from multiple individuals from all tissues at
various timepoints but not from the sera or urine. Fold change expression values
of the cytokine genes IFN-γ, TNFα, IL-6, IL-10, and TGFβ, as well as the antiviral
effector protein Oas1b, were quantified using the ΔΔCt method. Using a
MANOVA, it was discovered that both tissue type and collection timepoint had a
significant impact on cytokine gene expression (p = 0.01), suggesting that the
sampled immune genes are indeed expressed in a tissue- and time-specific
manner in deer mice infected with MODV. Corrected models of between-subject
tests depicted that IFN-γ, TNFα, and TGFβ were all significantly differently
expressed across tissues over time; however, Tukey HSD pos hoc analyses
revealed that IFN-γ alone was differentially expressed in the brain as compared
to all other tissues examined (p ≤ 0.01). Finally, a two-factor ANOVA
demonstrated a significant difference in the expression levels of Oas1b over time
but not between tissue types. Taken together, these findings suggest that deer
mice respond to MODV infection with a customized profile of cytokine genes that
are both tissue- and time-dependent. Additionally, as indicated by the expression
of the type I interferon (IFN)-stimulated gene (ISG) Oas1b, MODV does not
appear to antagonize the type I IFN response in a manner similar to other
flaviviruses.
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Introduction
Modoc virus (MODV) is a rodent-borne flavivirus that has been isolated
exclusively from wild deer mice in multiple states across the Western U.S. and
Canada (6, 67, 245). Morphologically, an enveloped virion encapsulates a
positive-sense, ssRNA genome of approximately 10.6 kb which is translated into
a single polyprotein that is co- and post-translationally cleaved to form three
structural (envelope, E; capsid, C; pre-membrane/membrane, prM) and seven
non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) proteins. In addition,
the 5’ end of the viral genome contains a methyl cap that mimics host transcripts
while the 3’ end encompasses various critical non-coding elements (e.g.,
subgenomic flaviviral RNA, sfRNA). As such, MODV belongs to the genus
Flavivirus (family Flaviviridae), along with other important representatives such
as West Nile virus (WNV), dengue virus (DENV), tick-borne encephalitis virus
(TBEV), and Zika virus (ZIKV), all of which are carried and transmitted through
arthropod vectors such as ticks and mosquitoes. Unlike these latter, however,
MODV cannot replicate within invertebrate cells and thus belongs to the
intrageneric cluster of flaviviruses with no known vector (NKV) (17).
Although the incident rate and disease severity of human infection with
NKV flaviviruses are far less concerning compared to their arthropod-borne
counterparts, it is not unprecedented. In at least two cases, rodent-borne NKVs
(MODV and Apoi, APOIV) have been indicated as the etiologic cause of illness
with neurologic involvement (i.e. encephalitis and meningitis, respectively) (64,
101). Similarly, bat-borne NKVs such as Dakar bat virus (DBV) and Rio Bravo
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virus (RBV) have caused isolated cases of disease in researchers working with
experimentally-infected individuals (64, 75). Aside from MODV and RBV, other
NKVs that have been isolated from wild-caught animals in North America include
the rodent-borne San Perlita (SPV), Sal Vieja (SVV), and Cowbone Ridge
viruses (CRV) as well as the bat-borne Montana myotis leukoencephalitis virus
(17, 64, 94). While these other NKVs have not yet been documented to cause
prominent clinical disease, antibodies against MODV and other MODV-like
viruses have been recovered from humans and small mammals in at least one
investigation suggesting that exposure to NKVs is not uncommon and that
replication in novel vertebrate hosts is possible (6).
To date, relatively few studies have utilized deer mice (Peromyscus
maniculatus) as rodent models for molecular or biomedical research (204).
Despite the extreme ubiquity of these rodents, most commercially available
reagents (e.g., antibodies) have been optimized for work with the common house
mouse (Mus musculus) and show poor cross-reactivity with peromyscines that
have undergone considerable evolutionary divergence from Mus (201). As such,
only a small subset of publications have described aspects of immune gene
regulation in deer mice during pathogenic infection (104, 190, 246, 247).
Fortunately, techniques such as reverse-transcription quantitative PCR (RTqPCR) have now become standard practice and provide the opportunity to
examine gene regulation and mechanisms of the subsequent immune response
in nearly any model of interest. In particular, deer mice pose an intriguing avenue
for infectious disease research given their ability to act as reservoir hosts for a
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variety of pathogens such as Powassan (POWV), deer tick (DTV), MODV, and
SVV flaviviruses, hantaviruses such as Sin Nombre (SNV) and New York-1 virus
(NYV), as well as a handful of bacteria and protozoa, most of which have been
indicated to cause moderate to severe disease in humans (64, 209-212, 217,
248-251). In cases such as these, examining the immune response of a natural
host may provide insight for the balanced immune response which prevents
pathology from both the infectious agent as well as the immune system itself
(185).
Currently, publicly available vaccines against medically relevant
flaviviruses are limited in both variety and accessibility. Likewise, there are no
FDA-approved antiviral drugs that can be enlisted to treat acutely infected
individuals. Given these deficiencies, coupled with the ever-increasing spread of
flaviviral distributions worldwide, the need for continued research to better
understand the mechanisms of flaviviral pathology has never been more vital.
Thus, despite the relatively low threat of clinical disease from NKVs, we feel
confident that important clues can nevertheless be obtained by utilizing MODV as
a unique model for further investigating universal aspects of flaviviral replication
kinetics, tissue tropism, and subsequent immune gene regulation during acute
infection. As the putative reservoirs of MODV, it is hypothesized that deer mice
will demonstrate no signs of clinical pathology throughout the experimental
duration. Likewise, despite the absence of any overt pathologies, infectious virus
and viral RNA should be detectable in various tissues at multiple timepoints;
however, quantities of detectable virus will be sustained at relatively low levels.
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Finally, it is hypothesized that relative expression values of the immune genes
IFN-γ, TNFα, IL-6, IL-10, and TGFβ will vary across tissues and over time,
thereby eliciting a tissue- and time-specific protective effect against both viral
burdens as well as immunopathologies that may accompany a sustained
proinflammatory response.
Materials and Methods
Ethics Statement and Animal
Husbandry
All of the methods conducted in this study were approved by the
University of Northern Colorado (UNCO) Institutional Animal Care and Use
Committee (IACUC; Protocol No. 1603C-AH-DmH-19) in accordance with the
Animal Welfare Act. Live deer mice (Peromyscus maniculatus) of both genders
(9 male and 9 female), aged 10-16 weeks old, were supplied from an established
breeding colony at UNCO.
Modoc Virus
Modoc virus (MODV; strain M544) obtained from ATCC (Manassas, VA,
USA) was passaged once in Vero E6 cells (ATCC) for seven days prior to
titration using the Reed-Muench 50% endpoint dilution assay.
Experimental Infections
Deer mice were inoculated intraperitoneally with 0.3 mL of MODV at an
infectious titer of approximately 104.2 TCID50/100mL (virus diluted in sterile 1x
DPBS; pH = 7.3). Likewise, negative control animals (6 of each gender) were
inoculated intraperitoneally with 0.3 mL of 1x DPBS (pH = 7.3). Following the
administration of virus or saline, all animals were housed individually and
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monitored daily for any signs of distress or morbidity (e.g., tachypnea, altered
gait, abnormal behavior, etc.). Experimentally infected animals were serially
euthanized at the following predetermined timepoints: 1, 2, 4, 6, 8, and 10 days
post-infection. Negative control animals were euthanized at 1, 6, and 10 days
post-infection. For all animals, euthanasia was performed by means of cervical
dislocation and cardiac exsanguination following anesthesia with isoflurane
vapors.
Sample Collection and
Preparation for the
Examination of
Replication
Kinetics
Necropsies were performed immediately following euthanasia and
included the collection of urine (extracted directly from the bladder using a
tuberculin syringe), blood sera (collected at the time of cardiac exsanguination
and separated by incubating at room temperature for 10 min, chilling on ice for
60 min, and then centrifuging at 4000 x g for 10 min), kidneys, liver, spleen, and
brain. All collected tissues were frozen immediately in liquid nitrogen baths and
stored at -80°C until further use. To prepare kidney, liver, spleen, and brain
tissues for RNA extraction and virus isolation, tissue samples of approximately
30 mg were first homogenized using a Mini-Beadbeater tissue disrupter
(Biospec, Bartlesville, OK, USA) with zirconia/silica beads in 600 uL of sterile 1x
PBS. Homogenates were then centrifuged through a QiaShredder column
(Qiagen, Germantown, MD, USA) at 14,000 x g for 8 min at 4°C to further
mechanically lyse cells and pellet cellular debris. Following centrifugation, 150 uL

83

of supernatant were aseptically removed and used for viral RNA extractiµon
while the remaining 450 uL were used for virus isolation. 10 uL of urine was first
removed from all samples for subsequent virus isolation, and remaining volumes
comprised of less than 140 uL were brought up to this volume with 1x PBS for
use in RNA extraction. In contrast, 140 µL of blood sera were first separated from
collected samples for use in RNA extraction; all remaining blood sera were then
used to perform viral isolation.
Extraction of Viral RNA and
Synthesis of Viral
cDNA
RNA was extracted from tissue homogenates, urine, and blood sera
samples using a QIAmp Viral RNA Mini kit (Qiagen, Germantown, MD, USA)
according to the manufacturer’s protocol. To reverse-transcribe viral RNA, 2 µL
of sample extract were first mixed with 5.2 µL of nuclease-free water and 2.8 µL
of MODV-specific forward and reverse primers (Eurofins, Louisville, KY, USA) at
a final concentration of 280 nM (66). RNA and primers were incubated at 94°C
for 1 min and then placed in an ice bath for 3 min before the addition of a mix
containing 0.5 µL of an Episcript RT enzyme and 2 µL of 10x RT buffer (Lucigen,
Radnor, PA, USA), 2 µL of DTT, 1 µL of dNTPs at 10 mM, 0.5 µL of a
recombinant RNase inhibitor (New England BioLabs, Ipswich, MA, USA), and 4
µL of nuclease-free water for a total final volume of 20 µL per reaction. Firststrand cDNA synthesis was carried out by incubating the entire reaction mixture
at 45°C for 1.5 hours, followed by 5 min at 85°C to halt enzymatic activity.
Samples were selected at random along with positive controls (obtained from
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stock suspensions of MODV) to assess for successful RNA extraction and cDNA
synthesis by conducting endpoint PCR using the manufacturer’s protocol for an
AccuStart II PCR SuperMix kit (Quantabio, Beverly, MA, USA), the same MODVspecific primers at a final concentration of 300 nM, and the following cycling
parameters: 5 min at 95°C followed by 40 cycles of 15 s at 95°C and 1 min at
60°C. Amplification of the expected gene product was observed using agarose
gel electrophoresis.
Quantification of Viral Loads
Using RT-qPCR
Absolute quantities of viral cDNA collected from select tissues were
assessed using RT-qPCR and MODV-specific primers that recognize a region
contained within the NS5 gene of the viral genome (66). To begin, the
amplification efficiencies were assessed by performing qPCR on 1:10 dilutions of
reverse-transcribed viral RNA extracted from stock MODV suspensions.
Following amplification efficiency optimization, qPCR analysis was conducted by
combining 2 µL of viral cDNA template with 10 µL of PerfeCTa SYBR FastMix
(Quantabio, Beverly, MA, USA), 2 µL of forward and reverse primers each at 3
µM, and 6 µL of nuclease-free water for a total final reaction volume of 20 µL.
Thermocycling was carried out on a CFX384 Touch (BioRad, Hercules,
California, USA) with the following conditions for both amplification efficiency
tests as well as analysis of collected samples: initial denaturation step at 95°C for
10 min followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. The generation
of a melt curve clarified the production of a single amplicon. Finally, 1:10 serial
dilutions of stock MODV cDNA were used to generate four standard curves from
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which the means were used to represent the tissue culture infective dose 50
(TCID50) “equivalent titer” of recovered viral RNA.
Virus Isolation from Select
Tissues
Following homogenization, tissue sample supernatants were prepared for
virus isolation by first creating suspensions containing 30% volume/volume (v/v)
fetal bovine serum (FBS; Corning, Corning, NY, USA). All samples were then
plated in triplicate on subconfluent layers of Vero E6 cells and incubated for 2.5
hours at 37°C and 5% CO2. Positive controls contained 1:10 dilutions of stock
MODV in 1x PBS and 30% v/v FBS while negative controls contained 30% v/v
FBS in 1x PBS alone. Following incubation, all samples and control inoculums
were removed, and cell monolayers were washed once with 1x PBS. Complete
DMEM culture media containing 2% v/v FBS was added to all wells, and plates
were incubated at 37°C and 5% CO2 for a maximum of 14 days or until negative
controls demonstrated any signs of senescence. Samples were scored as
positive for virus isolation if at least two of three wells indicated clear signs of
CPE. The same procedure as described above was utilized to detect infectious
virus in blood sera and urine (examined at a 1:10 dilution) samples given sample
availability for all infected animals in this study.
Sample Collection and
Preparation for
Examination
of Immune
Genes
Liver, spleen, kidney, and brain tissues were collected from infected
(biological triplicates) and mock-infected (biological replicates) deer mice at days
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1, 6, and 10 post-infection and to examine immune gene expression. All
specimens collected at the time of necropsy were immediately flash-frozen in
liquid nitrogen and held at -80°C until further use. Using a Mini-Beadbeater tissue
disrupter (Biospec, Bartlesville, OK, USA), approximately 30 mg of frozen tissue
were added to a 1.5 mL snap-cap tube containing TRK lysis buffer (E.Z.N.A Total
RNA kit, Omega Bio-Tek, Norcross, GA, USA), zirconia/silica beads, and 20
µL/mL of β-mercaptoethanol. Following tissue homogenization, entire
suspensions were transferred to a QiaShredder column (Qiagen, Germantown,
MD, USA) and centrifuged at 14,000 x g for 8 min at 4°C to further mechanically
lyse cells and pellet cellular debris. After spinning, supernatants were carefully
removed and utilized for RNA extraction, as described below.
RNA Extraction and cDNA
Synthesis
Total cellular RNA was extracted from tissue homogenate supernatants
using an E.Z.N.A Total RNA kit (Omega Bio-Tek, Norcross, GA, USA) according
to the manufacturer’s protocol. RNA extracts (eluded in 50 µL of nuclease-free
water) were assessed for concentration and purity using a Nanodrop 2000
spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA). For any
samples with 260/280 or 260/230 absorbance ratios below 1.8, an RNA cleanup
protocol was utilized in which samples were first q.s.’d to 50 µL with nucleasefree water before adding 5 µL of 3M sodium acetate (pH = 5.5) and 50.0 µL of
room temperature isopropanol. Samples were incubated at room temperature in
the dark for 20 min before centrifuging at 4°C for 10 min at 14,000 x g to pellet
RNA. Pellets were washed three times with ice-cold 70% ethanol, tubes were left
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open in an RNA hood for any remaining alcohol to evaporate, and finally, pellets
were resuspended in 50 µL of fresh nuclease-free water and reanalyzed for
purity and concentration. To determine RNA integrity, random samples were
selected and run through agarose gel electrophoresis. Prior to cDNA synthesis,
all samples were treated for genomic DNA contamination by using a PerfeCTa
DNase I removal kit (Quantabio, Beverly, MA, USA) according to the
manufacturer’s protocol. In brief, 1 ug of total RNA was mixed with 0.5 µL (1 U) of
recombinant DNase I, 1 µL of reaction buffer, and sufficient nuclease-free water
to constitute a final reaction volume of 10 µL. Samples were incubated for 30 min
at 37°C and then returned immediately to ice. 1 µL of DNase Stop Buffer
(provided in the same kit) was added to each sample and reactions were
incubated at 65°C for 10 min to halt the enzymatic activity of the DNase. Finally,
first-strand cDNA was synthesized by mixing the entire DNase-treated reaction
with 4 µL of qScript cDNA SuperMix (Quantabio, Beverly, MA, USA) and 5 µL of
nuclease-free water followed by incubation at 25°C for 10 min, 42°C for 30 min,
and then 85°C for 5 min.
Immune Gene Expression
Analysis
Prior to immune gene expression analysis, all of the primers used for this
study were first analyzed for amplification specificity and efficiency using
endpoint PCR and RT-qPCR, respectively. For the former, a minimum of two
experimental samples were utilized to conduct endpoint PCR using 2 µL of cDNA
template and an AccuStart II PCR SuperMix kit (Quantabio, Beverly, MA, USA)
according to the manufacturer’s protocol. Amplification of a single gene product
88

at the expected amplicon size was observed using agarose gel electrophoresis.
Primers were then assessed for amplification efficiency by conducting RT-qPCR
on 1:10 dilutions of the same template cDNA. All primers used for this study were
either recovered from published literature or manually designed by T. Sherman
with the aid of PrimerQuest and OligoAnalyzer (IDT). Details of all primer
sequences, amplification efficiencies, and gene accessions can be found in
Table 3.1.
Following satisfactory internal validation measures, analysis of immune
gene RT-qPCR was conducted by combining 2 µL of template cDNA (diluted to
10 ng/µL) with 5 µL of SsoAdvanced SYBR Supermix (BioRad, Hercules,
California, USA), 2 µL of forward and reverse primers each at 2 µM, and 1 µL of
nuclease-free water for a final total reaction volume of 10 µL. All samples were
run on a CFX384 Touch thermocycler (BioRad, Hercules, California, USA) with
the following conditions: initial denaturation step at 95°C for 10 min followed by
40 cycles at 95°C for 15 s and 60°C for 1 min. Additionally, melt curves were
generated for each sample, as described above. Relative gene expression was
calculated using the comparative Ct method (i.e., ΔΔCt) as proposed by Livak
and Schmittgen whereby immune genes were first normalized against the
constitutively-expressed β-actin gene (ΔCt) and then calibrated against the ΔCt
of mock-infected controls (ΔΔCt) (252). Finally, relative gene expression was
depicted as the mean fold change (2-ΔΔCt) ± standard error of the mean (SEM)
between infected and mock-infected animals at each of the previously described
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collection timepoints. Samples that did not generate a Ct value were given a
default value of 40.
Statistical Analysis
Log10 transformations were first applied to all relative gene expression
values prior to any downstream statistical analysis. Using SPSS v25.0 (IMB,
Armonk, New York, USA), separate MANOVAs were utilized to assess for
significant differences in the gene expression levels a) between all tissues and
collection timepoints and b) between collection timepoints within brain tissues
alone. Additionally, a two-factor ANOVA was used to examine the relative
expression levels of Oas1b between tissues at each collection timepoint. For all
analyses, significant differences between groups were evaluated using corrected
models and an alpha significance of 0.05.
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Table 3.1: Sequence data and amplification efficiencies for deer mouse
primers.
Target Primer Sequence (5’ to 3’)
β-Actin
Fw GCTACAGCTTCACCACCACA
Rv TCTCCAGGGAGGAAGAGGAT
Oas1b
Fw CAGTATGCCCTGGAGCTGC
Rv GTACTTGGTGACCAGTTCC
IFN-γ
Fw ACAGCAGTGAGGAGAAACGG
Rv GACAGGCGGTACATCACTCC
TNFα
Fw GGGCTGTACCTCGTCTACTC
Rv ACAGGAGGTTGACTTTGTCC
TGFβ
Fw CGTGGAACTCTACCAGAAATACAGC
Rv TCAAAAGACAACCACTCAGGCG
IL-6
Fw CCATCCAACTCATCCTGAAAGC
Rv CCACAGATTGGTACACATAGGCAC
IL-10
Fw CAGACCTACACGCTTCGAG
Rv CCCAGGTAACCCTTAAAGTCC
MODV-NS5
Fw CCAGGACAAGTCATGTGGTAGC
Rv TCCCAAAGATGTTCCTCACCTT
Table 2

Size

R2

Eff. (%)

Gene Accession

Reference

123

1.000

102.0

XM_006998174.2

Mallarino et
al., 2016 (253)

111

0.998

98.3

XM_006970848.1

This study

115

0.970

94.7

AY289494.1

This study

121

0.999

100.4

XM_006995235.2

This study

96

0.999

95.6

XM_006988036.2

Schountz et
al., 2012 (190)

101

0.999

96.1

AY256518.1

Schountz et
al., 2012 (190)

128

0.999

111.2

XM_006995328.2

This study

101

0.998

107.5

NC_003635.1

Leyssen et al.,
2001 (66)

Results
Modoc Virus Replicates to Low
Levels in Deer Mouse Tissues
Viral RNA in select deer mouse tissues (spleen, kidneys, liver, and brain)
and bodily fluids (blood sera and urine) could be quantified by RT-qPCR as early
as 24 hours post-intraperitoneal infection and remained detectable throughout
the entire 10-day experimental period (Figure 3.1 and 3.2). Interestingly, the
examination of MODV RNA in these tissues revealed a relatively consistent trend
in which viral loads were maintained at an equilibrium roughly one order of
magnitude less than that of the experimentally-administered infectious dose
(mean loads among all tissues = 103.0 TCID50 infective dose equivalent, SEM =
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102.2). Likewise, viral RNA loads in the urine and sera remained comparatively
low throughout the study duration (mean loads in urine = 10 2.4, SEM = 101.9 and
sera = 102.7, SEM = 102.3).
In regard to viral replication kinetics in individual tissues and fluids, the
results of this study predominantly corroborate published data from the limited
number of previous in vivo investigations of deer mice experimentally infected
with MODV. Specifically, minimal viral RNA shed in the urine with a peak quantity
detected at day 6 post-infection supports findings by Davis et al. in which viruria
was observed on days 4 to 6 post-intranasal inoculation (8). Similarly, higher
loads of viral RNA in the sera early during infection (days 1 to 4) correlate with
viremia detected during the same timeframe in two separate studies following
both intranasal and intraperitoneal challenge (8, 254). Detection of viral loads in
liver, for which mean values were the lowest among all tissues throughout the
experiment (mean = 102.6, SEM = 102.0), matches findings by Davis et al. in which
virus isolation was barely quantifiable throughout a 10-day infection period.
Further, both this study as well as the work conducted by Davis et al.
demonstrate selective replication of MODV in the spleen (mean = 10 3.2, SEM =
102.7) with a peak titer at day 6 post-infection (both studies) even when routes of
inoculation differ (intranasal versus intraperitoneal). Levels of MODV RNA
detected in deer mouse kidneys were reminiscent of patterns observed by Davis
et al. in which viral loads appear to peak and then declined every 2 to 4 days but
remain relatively low throughout the study period (mean = 10 2.7, SEM = 102.1).
Finally, in contrast to the aforementioned tissues and fluids, quantification of
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MODV RNA in the brain (mean = 103.0, SEM = 102.0) of infected deer mice did not
parallel the results of virus isolation in the Davis et al. investigation; however, this
could be explained by the decreased sensitivity for detection in virus isolation
methods which utilize cell culture as compared to the detection of viral nucleic
acids via RT-qPCR.
To glean additional clues about the tropism of MODV in deer mouse
tissues, this study also conducted virus isolation utilizing cell culture methods,
which allow for the detection of infectious virus present at the time of tissue
collection. In brief, no infectious virus was detected in the urine (n = 18)
throughout the entire experimental period or in the sera (n = 5) of any individuals
past day 8 post-infection. In all tissues tested, infectious virus was recovered
from at least 2 of 3 bioreplicants on days 8 and 10 post-infection with additional
isolations in at least 1 of 3 replicants on day 1 (liver), day 2 (spleen), day 4
(kidneys and brain) and day 6 (brain) post-infection. Interestingly, these findings
suggest an increased tropism of MODV toward the brain and liver compared to a
higher frequency of successful isolations in the spleen as demonstrated by Davis
et al. Granted, it is unfortunate to report that samples from multiple replicants at
mid-collection timepoints from all tissues in the present study were lost due to
fungal contamination during plate incubation and thus could not be included in
this examination. Due to this shortcoming, a more exact illustration of tissue
tropism during acute infection could not be constructed.
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Figure 11
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Figure 3.1: Viral RNA loads detected in the urine and blood sera of infected
deer mice over a 10-day infection period. Mean (log10) viral loads were
quantified using two-step RT-qPCR and translated into TCID50 “equivalent titers.”
A limit of detection (dotted grey line) was created by conducting RT-qPCR on
MODV RNA template that had not undergone reverse-transcription.
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Figure 12
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Figure 3.2: Recovery of infectious virus and viral RNA in select tissues
collected from infected deer mice over a 10-day infection period. Mean
(log10) viral loads were quantified using two-step RT-qPCR and translated into
TCID50 “equivalent titers” (primary vertical axis). Isolation of infectious virus from
biotriplicates at each collection timepoint was deemed positive if at least two of
three wells indicated clear signs of virally-induced CPE when homogenized
tissues samples were incubated with Vero cells (secondary axis).
Immune Genes Are Differentially
Expressed in the Brain of Deer
Mice During Acute Infection
with Modoc Virus
The transcript expression levels of five immune genes (IFN-γ, TNFα, IL-6,
IL-10, and TGFβ) were analyzed using RT-qPCR following in vivo experimental
infections of deer mice with MODV. At three distinct timepoints (1, 6, and 10
d.p.i.), animals were euthanized and necropsied for the collection of kidney,
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spleen, liver, and brain tissues. Given the predicted variance that may occur
between gene expression levels, a log10 transformation was applied to all relative
expression values prior to any downstream statistical analysis. Once
transformed, a Shapiro-Wilk test for normality confirmed that all expression
values were normally distributed (p ≥ 0.11) except for one instance (TGFβ in liver
tissues; p = 0.04).
Mapping the expression levels of these genes across all tissues and
timepoints (n = 3 per gene) in principle component analyses (PCA) revealed
clustering which suggests that there are patterns of differential expression in the
brain compared to the kidney, spleen, and liver tissues (Figure 3.3) as well as
between collection timepoints (Figure 3.4).
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Figure 13

Figure 3.3: Principle component analysis (PCA) of gene expression in
MODV-infected deer mice. Plots were created in PC-ORD (V7.0) using log 10
transformations of gene expression data (randomized tests, 999 runs). When
grouped by tissue, gene expression values cluster differentially in brain tissues
(save for one outlier) as compared to kidneys, spleen, and liver tissues.
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Figure 14

Figure 3.4: Principle component analysis (PCA) of gene expression in
MODV-infected deer mice. Plots were created in PC-ORD (V7.0) using log10
transformations of gene expression data (randomized tests, 999 runs). When
grouped by collection timepoint, gene expression values appear to cluster more
tightly at the first and last collection timepoints as compared to the mid-collection
timepoint.
To further clarify whether the patterns observed in the principle component
analyses were statistically meaningful, a multivariate analysis of variance
(MANOVA) was enlisted to identify the significance of all gene expression levels
when both tissue and collection timepoint are treated as fixed factors. To this
end, it was discovered that both interactions were significant (p < 0.00),
suggesting that these immune genes are indeed expressed in a tissue- and time98

specific manner in deer mice infected with MODV. Moreover, corrected models of
between-subject tests revealed that IFN-γ (p < 0.00), TNFα (p < 0.00), and TGFβ
(p < 0.00), were all significantly differently expressed, while IL-10 (p = 0.06)
demonstrated marginally significant differential expression. In contrast, IL-6 (p =
0.14) does not appear to be significantly differential expressed between the
selected tissues or at the timepoint collected. Tukey HSD pos hoc analyses
revealed that individual genes may be significantly differentially expressed in
separate tissues; however, IFN-γ was the only gene found to be differentially
expressed in one particular tissue (brain) as compared to all other tissues
examined (p ≤ 0.01).
Lastly, a separate MANOVA was conducted using samples collected from
brain tissues alone to further elucidate any significant variation in the expression
level of all genes between collection timepoints. For this analysis, brain tissue
was chosen for scrupulous examination given the finding that the expression of
IFN-γ was significantly different as compared to all other tissues and because
MODV has been documented to cause neurologic disease in certain rodent
models and one instance of human infection. To this end, corrected models for
between-subjects effects revealed that only TNFα was significantly differentially
expressed between all timepoints (p < 0.00). However, it may be noteworthy to
highlight that IFN-γ displays a unimodal expression pattern while all other genes
(except for IL-10, which could not be detected at 10 days post-infection) display
gradually increasing levels of expression throughout the experimental duration
(although the variance in expression for this gene at day 6 is high) (Figure 3.5).
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Along with this, Tukey HSD post hoc analysis shows that expression of TNFα
differed significantly between days 1 and 6 (p = 0.01) as well as days 1 and 10 (p
< 0.00) but not between days 6 and 10 post-infection (p = 0.53).
Figure 15

Figure 3.5: Gene expression levels in select tissues of MODV-infected deer
mice. Relative expression levels were determined using the ΔΔCt method (n = 3
per timepoint) as described by Livak and Schmittgen (252). DPI; days postinfection.
The Flavivirus Resistance Gene
Oas1b is Significantly
Upregulated During
Early Infection with
Modoc Virus
A sixth immune gene, Oas1b, was chosen as an indicator of the
intracellular antiviral immune response following experimental infection. To
100

assess for significant differences in Oas1b gene expression between tissues and
over time, a two-factor univariate analysis of variance (ANOVA) was used in
which tissue and collection timepoint were treated as fixed factors. Results from
this ANOVA indicated that there was a significant difference in expression levels
between collection timepoints (p ≤ 0.00) but not between the tissues examined (p
= 0.25). Further, Tukey HSD pos hoc analysis suggested that the expression of
Oas1b across all tissues did not differ significantly between days 1 and 6 postinfection (p = 0.30), but rather, demonstrated a consistent pattern of early
upregulation that was maintained until at least day 6 post-infection followed by a
significant decrease (p < 0.00) in expression sometime before day 10 postinfection (Figure 3.6).
Figure 16

Figure 3.6: Expression levels of Oas1b captured in selected tissues of
MODV-infected deer mice. Relative expression levels were determined using
the ΔΔCt method (n = 3 per timepoint) as described by Livak and Schmittgen
(252). DPI; days post-infection.
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Discussion
In regard to overt disease, no deer mice infected with MODV
demonstrated any indications of distinguishable morbidity (characterized by
ruffled fur or piloerection, fluid discharge from the nose, mouth or eyes,
hematuria, muscle weakness, tremor, flaccid paralysis, or general lethargy and
changes in behavior) throughout the entire experimental duration. Despite this,
viral RNA could be detected in multiple tissues and fluids from 24 hours postinfection until the end of the experiment at 10 days post-infection. Moreover,
infectious virus could be recovered from multiple tissues in multiple individuals at
various collection timepoints. Taken together, these observations corroborate
previous investigations with MODV in deer mice and add further support to the
proposition that these rodents may function as the natural reservoir hosts of the
virus in nature. Finally, by mimicking the inoculation dose and route of MODV
used in earlier studies, which demonstrate paralytic syndromes in Syrian golden
hamsters and SCID mice around 9 days post-infection, the research presented
here confirms the of use of deer mice as a comparatively non-pathogenic model
during acute infection with MODV (66, 96).
The observed levels of MODV in select tissues and fluids, as determined
by the quantification of viral RNA using RT-qPCR, likewise indicates that
infection in deer mice is non-pathogenic and may in fact be under tight regulatory
control given that viral loads are maintained at consistently low levels even when
exposure to the virus is unnaturally high (as in the case of experimental
infection). In the sera, viral loads from this study coincide with previous flaviviral
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investigations, which describe that the highest mean titers are detected early
post-infection and begin to wane by days 4-6 (8, 254, 255). As compared to
MBFVs and TBFVs, though, MODV does not appear to approach the higher titers
of viremia required to infect an invertebrate vector (e.g., 10 5.0 PFU/mL threshold
to infect Cx. pipiens and Cx. quinquefasciatus with WNV) (256). Granted, this
study utilized a technique for viral detection (RT-qPCR), which does not
necessarily equate to functional levels of infectious virus; however, it would be
highly improbable that the titers of infectious virus exceed those of corresponding
RNA loads given that viral RNA may be detected from both infectious and noninfectious particles. In any case, there were no successful viral isolations from
any of the deer mouse sera samples tested (in total, 2/3 individuals were tested
on day 8, and 3/3 individuals were tested on day 10 post-infection).
Patterns of viral replication in the spleen and liver grossly adhere to prior
investigations that depict more or less tropism toward these tissues, respectively
(8). In part, this may be explained by the fact that many flaviviruses tend to
preferentially infect monocyte-derived cells (of which many can be found in the
murine spleen compared to the liver) (257-259). Indeed, while hepatic tropism is
apparent in the case of YFV, the alternative tropism toward splenic tissues has
been demonstrated in at least two other MBFVs, WNV and ZIKV (260, 261). In
contrast, low viral loads detected in the kidneys and urine (with no infectious
virus isolated from 1:10 dilutions of urine for any animals) support the assertion
that MODV in deer mice is less trophic toward renal tissues; in combination with
previous studies demonstrating higher titers detected in the lungs, salivary-
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submaxillary glands, or mammary tissues, there is a strong argument for
horizontal transmission to occur through direct contact as opposed to
excremental shedding (8, 92). Lastly, detection of viral RNA in the brain was
unsurprising given the neurotrophic nature of MODV depicted in earlier studies
(66, 95). Nevertheless, a trending decrease in viral loads in the brain beginning
at day 8 post-infection suggest that deer mice are able to control virus replication
in brain tissues to an extent which prevents CNS-like disease (although the
observed decrease is not yet significant by day 10).
The immune genes examined in this study represent a very small subset
of a much larger conglomerate of molecules which act either in synchrony or
antagonistically to elicit a productive immune response against any given
pathogen. Known more specifically as cytokines, these molecules may serve as
the “alarm bells” of pathogen infection (e.g., IFN-γ), as proinflammatory
mediators (e.g., TNFα and IL-6), or as immunomodulatory regulators (e.g., IL-10
and TGFβ). Importantly, it is believed that the level of expression for each, as
well as the timing of expression, may ultimately lead to the coordination of an
immune response which either leads to a) pathogen clearance, b) pathogen
tolerance, or c) disease as a result of uncontrolled pathogen replication or
collateral damage from the immune response itself (or both).
In particular, transcripts for interferon-gamma (IFN-γ or type II IFN), which
serves multiple important functions in controlling microbial invasion and
physiologic homeostasis, were discovered to be significantly differentially
expressed in the brain as compared to all other tissues (Tukey HSD, p ≤ 0.01).
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This finding is in accordance with the transcriptome profiling data of deer mice
infected with Powassan virus (POWV), a tick-borne, neurotrophic flavivirus,
demonstrating that the differential expression of IFN-γ is significant in the brain
from days 3 to 15 post-infection (247). Further, the importance of IFN-γ
functionality has been reported in the context of infection with WNV, another
flavivirus with neurotrophic potential (262). By comparing viral replication and the
host response in wild-type mice to that of either IFN-γ-/- or IFN-γR-/- knockouts, it
was found that individuals which lacked the ability to produce or respond to IFN-γ
signals succumbed to lethal infection faster and more frequently under the
burden of higher viremia and viral replication in the lymphoid tissues (the latter of
which is believed to influence viral invasion into the central nervous system, or
CNS). At the same time, separate studies have shown that the subsequent
downregulation of IFN-γ following initial virally-induced expression is of equal
importance to avoid disintegration of the blood-brain barrier (BBB) (263). This
considered, and in light of the perceived necessity for the presence and timing of
IFN-γ expression in previous studies with neurotrophic flaviviruses, it appears
fitting that deer mice respond to MODV infection in the brain via the significant
but unimodal expression of IFN-γ which may correlate with the decline in viral
loads witnessed at the final collection timepoint (Figure 3.5).
While none of the other cytokine genes examined display the same
statistical significance in the brain as IFN-γ, it is interesting that TNFα and IL-6
display increasing levels throughout the experimental duration with expression
values that differ significantly compared to uninfected controls by days 6 and 10
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post-infection. Tumor necrosis factor alpha (TNFα), like IFN-γ, serves myriad
roles in antimicrobial immunity as well as normal physiologic homeostasis (264).
As an antiviral, TNFα elicits fever, stimulates the expression of acute-phase liver
proteins, and may induce apoptosis in infected endothelial cells, among other
functions. Similarly, IL-6 helps to orchestrate the aforementioned immune
armaments in addition to promoting inflammation, which aids in leukocyte
migration to areas of viral infection. Indeed, both of these cytokines have been
correlated with positive clinical outcomes of viral disease; however, atypically
high levels of each have been found in instances of severe flaviviral illness under
both the context of CNS involvement (JEV) as well as hemorrhagic fevers
(DENV) (143, 265, 266). It is therefore tempting to postulate that deer mice
exhibit an expression pattern that productively controls viral replication in the
brain without the consequence of immunopathology which may accompany a
fulminant inflammatory response.
Perhaps most interesting is the observed expression of Oas1b, an antiviral
effector protein induced by IFN-α/β (i.e. type I IFN) signaling. Although we chose
not to examine type I IFN transcripts (primarily due to the absence of any verified
IFN-α/β transcript sequences for peromyscines in the NCBI database), it is well
known that many flaviviruses antagonize this vital antiviral signaling system with
a plethora of strategies (123, 126, 267, 268). Moreover, there is evidence that
some of these strategies are conserved among diverse flaviviruses (e.g., WNV
vs. JEV), implicating that research examining counter-antagonism using less
pathogenic representatives (e.g., MODV) may still lead to novel therapies
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applicable to more virulent members (66, 123). Therefore, as an alternative to
examining transcript levels of the type I IFNs themselves, we choose to examine
an IFN-stimulated gene (ISG) as a quantifiable downstream indicator of
productive type I IFN signaling (269). In Mus, it is known that the Oas1b isoform
of the Oas1 protein is particularly efficacious toward controlling infection of WNV
(270-273). In one particular study examining transcriptional regulation in Mus
models during infection with WNV, expression of Oas1b was observed to be
increased in the spleen during infection from seven distinct strains of the virus
(274). In the present study, we found that Oas1b is significantly expressed in all
examined tissues as compared to uninfected controls within the first 24 hours of
infection and remains significantly expressed to a high degree until some point
after the collection period at 6 days post-infection. Indeed, the near-immediate
and extreme expression of these transcripts imply that MODV recognition in deer
mice is rapid and leads to the activation of antiviral ISGs through productive type
I IFN signaling. This observation lends promise for continued future
investigations, given the results of separate studies depicting the importance of
virus-specific ISGs and their role in limiting tissue-specific infections (247, 275,
276).
Conclusions and Future Directions
While it has been established that deer mice are capable of hosting a
variety of bacterial, protozoic, and viral pathogens, relatively little molecular work
has been conducted to understand the ability of these rodents to act as reservoir
hosts, which avoid overt disease. Historically, studies examining cytokine gene
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expression in the peromyscine immune response involved models of infection by
members of the genus Orthohantavirus (family Hantaviridae) (190, 246). In these
examples, it appears as though higher expression of transforming growth factor
beta (TGFβ) at later timepoints of infection (between 15 and 45 days postinfection) leads to immune suppression that fails to clear viral infection but
prevents immunopathology caused by a sustained proinflammatory response.
More recently, models have been constructed using deer mice to examine
flaviviral pathology; however, these models either utilize in vitro methods that
may fail to capture the whole-animal response or exploit TBFVs (e.g., POWV)
that must be manipulated solely in specialized biosafety level-3 (BSL-3) facilities
(104, 247). To complement these studies and contribute further to the increasing
knowledge of virus-reservoir-host relationships, as well as the intricate
discrepancies between various flavivirus replication strategies and disease
pathologies, the research presented here, therefore, takes advantage of a
rodent-borne flavivirus to conduct an in vivo investigation of the immune
response during acute infection in the virus’s putative reservoir host in a BSL-2
laboratory.
Future investigations related to the research presented here may wish to
extend the duration of experimental infection to better capture ongoing changes
to viral replication kinetics, tissue tropism, and the host response potentially
missed by only examining the first 10 days following infection. Likewise, it could
be interesting to include an examination of the lungs and salivary-submaxillary
glands from which Davis et al. recovered the highest titers of MODV from all
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examined tissues in infected deer mice (8). Increasing the sample size of
replicates per collection timepoint and limiting the animals used in the study to a
single sex may help to alleviate some of the variance observed with gene
expression analyses (Appendix B); however, this variation may nevertheless
persist given the relatively outbred nature of deer mice as compared to other
laboratory rodents (190). Finally, proteomic studies should be used to
compliment gene expression analyses such that post-transcriptional events can
be resolved and interactions between cellular and viral proteins can be
elucidated.
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CHAPTER IV
COMPARATIVE HOST RESPONSE AND GENE
REGULATION IN DEER MICE AND SYRIAN
GOLDEN HAMSTERS DURING ACUTE
INFECTION WITH MODOC VIRUS
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Abstract
Despite their pervasive distribution and global burden on public health, the
factors which influence the outcome of clinical disease upon infection with
flaviviruses (family Flaviviridae, genus Flavivirus) remain incompletely
understood. While it is known that differences in the host innate immune
response will subsequently influence aspects of viral tropism, dissemination, and
long-term persistence, it is challenging to delineate which factors are protective
and which may contribute to immunopathogenesis. In an attempt to shed light on
this matter, we have chosen to examine the patterns of viral replication and
immune gene expression in two unique rodent models during acute infection with
Modoc (MODV), a rodent-borne flavivirus. Deer mice (Peromyscus maniculatus)
and Syrian golden hamsters (Mesocricetus auratus) were challenged
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intraperitoneally and serially euthanized over a 10-day period. Using RT-qPCR, it
was determined that viral RNA could be detected from 24 hours post-infection in
the kidneys, spleen, liver, brain, urine, and sera. In hamsters, the levels of viral
RNA generally began lower than in deer mice, increased in every tissue and fluid
by day 4, and then remained generally higher in all tissues except for the spleen
and liver. Infectious virus could be recovered from all tissues in the deer mice but
only at later timepoints. In contrast, infectious virus could only be recovered from
the kidneys and liver of hamsters, although virus isolation was successful at all
timepoints examined. Neither viremia nor viruria was evident for either animal
during the experimental period. The expression of five important cytokine genes
(IFN-γ, TNFα, IL-6, IL-10, and TGFβ) as well as an anti-flaviviral effector protein
Oas1b were also examine using RT-qPCR and the ΔΔCt method. Statistical
analysis with a MANOVA suggests significance in the complete expression
profile of cytokine genes when examined across tissues and over time between
rodent species (p = 0.02). Further, between-subject effects with corrected models
revealed a significant difference specific to the expression IFN-γ (p = 0.01). In
support of this, the relative expression of IFN-γ in the brains of infected hamsters
was significantly higher than that of deer mice by day 6 post-infection and
persistent until the end of the experiment. As over-expression of IFN-γ has
occasionally been shown to correlate with losses in vascular integrity, the
findings presented here may highlight a potential mechanism for viral
dissemination into the CNS following fulminate activation of cells from the innate
response (e.g., NK cells). This could explain the increase in viral RNA detected in
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the brains of hamsters followed by the paralytic syndromes, which often develop
in these animals (neither of which appears to occur in the deer mice).
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Introduction
Flaviviruses represent a taxonomic collective of globally-distributed,
predominantly vector-borne pathogens that may elicit a vast range of clinical
pathologies. Fortunately, the majority of human infections appear to self-resolve
following only mild or subclinical illness; however, instances of severe disease
are not uncommon and may result in multiple-organ failures, autoimmune
disorders, malformations in fetal development, hemorrhagic fevers with vascular
leak syndromes, or meningioencephalitic ailments with the potential for
permanent neurologic sequelae (11, 277). Moreover, a significant increase in the
spread and incidence of flaviviral disease has provoked renewed concern for the
burden of these viruses on global public health (61, 180, 278). For perspective,
dengue virus (DENV), now considered to be the most common vector-borne
virus in the world, infects more than 390 million individuals annually (95%
confidence interval) and leads to clinical disease in approximately 96 million (10,
279). Other notable representatives such as West Nile virus (WNV), Japanese
encephalitis virus (JEV), yellow fever virus (YFV), and the newly emergent Zika
virus (ZIKV) continue to threaten individuals worldwide, with a conservative
estimate of annual infection approaching nearly 4 billion (3, 4, 59, 78, 82). The
issue of exposure is further compounded by anthropogenic impacts on the
environment (e.g., global warming and plastic waste production), leading to
range expansion for vectors like ticks and mosquitoes which carry and transmit
flaviviruses (among others) (5, 83, 85, 88, 279). Combined with a relative lack of
flaviviral vaccine availability and FDA-approved antiviral therapies for those at
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risk or acutely infected, the need for continued research with these pervasive
pathogens is apparent (10).
As a member of the genus Flavivirus, Modoc virus (MODV) is
characterized by an enveloped, (+)ssRNA genome that encodes a total of three
structural (envelope, E; capsid, C; pre-membrane/membrane, prM) and seven
non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) proteins. Further,
the 5’ end of the viral genome contains a methyl cap that mimics host transcripts
while the 3’ end encompasses various non-coding elements (e.g., subgenomic
flaviviral RNA, sfRNA), all of which have been universally speculated to
contributed to flaviviral infectivity and transmission, replication, and host
pathogenesis (51, 94, 280, 281). In contrast to the aforementioned flaviviruses,
however, isolation of infectious MODV has occurred exclusively from wild deer
mice (Peromyscus spp.) in nature and cannot be recovered from passage in both
invertebrate as well as vertebrate cell lines for unknown reasons (52, 67, 92,
100). Given this restriction in vector/host range, MODV belongs to a group of
other related flaviviruses known as the no known vector (NKV) cluster (17). To
date, only a few instances of clinical human disease caused by NKVs have been
officially documented (75, 101). Still, NKVs like MODV may provide an attractive
avenue for continued flaviviral research given their ability for manipulation at
biosafety level-2 (BSL-2) facilities and capacity to recapitulate examples of
human-like flaviviral disease in rodent models (e.g., mild febrile illness with the
potential for reproductive or CNS involvement (96, 282).
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As the putative reservoir hosts of MODV in nature, as well as a variety of
other viral, bacterial, and eukaryotic pathogens, infectious disease research with
peromyscines has questioned the immunoregulatory processes at play which
prevent overt disease in these rodents (188, 190, 246). On the opposite end of
the spectrum, Syrian golden hamsters (Mesocricetus auratus) can be utilized as
models which develop disease reminiscent of human infections from many
pathogens without the need for genetic manipulation or chemical
immunocompromise necessary in other rodent models such as Mus musculus
(66, 234, 283, 284). Indeed, both animals have been enlisted to study facets of
MODV ecology and infection in the past and have revealed clues about the
potential tropism and subsequent pathology of MODV in vivo (7, 8, 65, 92, 95,
254). In particular, it is known that MODV will induce a poliomyelitis-like
syndrome in hamsters that appears absent from deer mice when experimentally
infected through the same route (separate studies) (66, 254). Granted, no studies
thus far have included an examination of any immune genes expressed during
acute infection.
Due to their medical relevance, mosquito-borne (MBFVs) and tick-borne
flaviviruses (TBFVs) have been studied extensively over the preceding decades.
Indeed, advances in molecular techniques have created many opportunities for
refining the scientific and medical communities’ current understanding of flaviviral
ecology and disease. Despite this, many questions still remain with regard to the
precise details which influence flaviviral transmission, replication, tissue tropism,
immune subversion strategies, and subsequent disease pathologies.
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Nevertheless, there appears to be sufficient justification to postulate that the
exact mechanisms leading to the various observed outcomes of infection
culminate as the result of a host individual’s unique immune response (45, 124,
147, 148, 150, 268, 285, 286). As such, investigations that directly compare the
immune response in terms of cytokine gene expression between different models
of disease may offer a novel approach to elucidating the underlying mechanisms
which lead to either viral clearance/persistence or pathology. Here we present
one such approach which utilizes MODV, the most well-characterized NKV, to
compare and contrast the discrepancies in viral replication kinetics, tissue
tropism, and immune gene expression between deer mice and Syrian golden
hamsters during an acute duration of experimental infection. Therefore, it is
hypothesized that Syrian golden hamsters will demonstrate clinical signs of
pathology when infected with MODV, thereby constituting a comparative
pathogenic model. As such, viral loads should differ significantly in various
tissues over time when compared to deer mice. Finally, the relative expression
values of immune genes should differ significantly between hamsters and deer
mice in various tissues at distinct timepoints throughout the experimental
duration, highlighting the different modalities of immune regulation elicited by
each rodent model even when pathogen dose and route of infection are
standardized.
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Materials and Methods
Ethics Statement and Animal
Husbandry
All of the methods conducted in this study were approved by the
University of Northern Colorado (UNCO) Institutional Animal Care and Use
Committee (IACUC; Protocol No. 1603C-AH-DmH-19) in accordance with the
Animal Welfare Act. Live deer mice (Peromyscus maniculatus) of both genders
(9 male and 9 female), aged 10-16 weeks old, were supplied from an established
breeding colony at UNCO while Syrian golden hamsters (Mesocricetus auratus)
were purchased from Envigo Laboratories (Denver, CO, USA).
Modoc Virus
Modoc virus (MODV; strain M544) obtained from ATCC (Manassas, VA,
USA) was passaged once in Vero E6 cells (ATCC) for seven days prior to
titration using the Reed-Muench 50% endpoint dilution assay.
Experimental Infections
Eighteen deer mice and eighteen hamsters (nine of each gender for each
species) ranging in age from 10-16 weeks old were inoculated intraperitoneally
with 0.3 mL of MODV at an infectious titer of approximately 10 4.2 TCID50 (virus
diluted in sterile 1x DPBS; pH = 7.3). Likewise, negative control animals (12 of
each species, 6 of each gender) were inoculated intraperitoneally with 0.3 mL of
1x DPBS (pH = 7.3). Following administration of virus or saline, all animals were
housed individually with free access to food and water and monitored daily for
any signs of distress or morbidity (e.g., tachypnea, altered gait, abnormal
behavior, etc.). As well, all animals were weighed daily beginning at 24 hours
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post-infection and subsequently throughout the entire experimental period.
Experimentally infected animals were serially euthanized at the following
predetermined timepoints: 1, 2, 4, 6, 8, and 10 days post-infection. Negative
control animals were euthanized at 1, 6, and 10 days post-infection. For all
animals, euthanasia was performed by means of cervical dislocation and cardiac
exsanguination following anesthesia with isoflurane vapors.
Sample Collection and
Preparation for the
Examination of
Replication
Kinetics
Necropsies were performed immediately following euthanasia and
included the collection of urine (extracted directly from the bladder using a
tuberculin syringe), blood sera (collected at the time of cardiac exsanguination
and separated by incubating at room temperature for 10 min, chilling on ice for
60 min, and then centrifuging at 4000 x g for 10 min), kidneys, liver, spleen, and
brain. All collected tissues were frozen immediately in liquid nitrogen baths and
stored at -80°C until further use. To prepare kidney, liver, spleen, and brain
tissues for RNA extraction and virus isolation, tissue samples of approximately
30 mg were first homogenized using a Mini-Beadbeater tissue disrupter
(Biospec, Bartlesville, OK, USA) with zirconia/silica beads in 600 µL of sterile 1x
PBS. Homogenates were then centrifuged through a QiaShredder column
(Qiagen, Germantown, MD, USA) at 14,000 x g for 8 min at 4°C to further
mechanically lyse cells and pellet cellular debris. Following centrifugation, 150 µL
of supernatant were aseptically removed and used for viral RNA extraction while
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the remaining 450 µL were used for virus isolation. 10 µL of urine was first
removed from all samples for subsequent virus isolation and remaining volumes
comprised of less than 140 µL were brought up to this volume with 1x PBS for
use in RNA extraction. In contrast, 140 µL of blood sera were first separated from
collected samples for use in RNA extraction; all remaining blood sera were then
used to perform viral isolation.
Extraction of Viral RNA and
Synthesis of Viral cDNA
RNA was extracted from tissue homogenates, urine, and blood sera
samples using a QIAmp Viral RNA Mini kit (Qiagen, Germantown, MD, USA)
according to the manufacturer’s protocol. To reverse-transcribe viral RNA, 2 µL
of sample extract were first mixed with 5.2 µL of nuclease-free water and 2.8 µL
of MODV-specific forward and reverse primers (Eurofins, Louisville, KY, USA) at
a final concentration of 280 nM (66). RNA and primers were incubated at 94°C
for 1 min and then placed in an ice bath for 3 min before the addition of a mix
containing 0.5 µL of an Episcript RT enzyme and 2 µL of 10x RT buffer (Lucigen,
Radnor, PA, USA), 2 µL of DTT, 1 µL of dNTPs at 10 mM, 0.5 µL of a
recombinant RNase inhibitor (New England BioLabs, Ipswich, MA, USA), and 4
µL of nuclease-free water for a total final volume of 20 µL per reaction. Firststrand cDNA synthesis was carried out by incubating the entire reaction mixture
at 45°C for 1.5 hours, followed by 5 min at 85°C to halt enzymatic activity.
Samples were selected at random along with positive controls (obtained from
stock suspensions of MODV) to assess for successful RNA extraction and cDNA
synthesis by conducting endpoint PCR using the manufacturer’s protocol for an
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AccuStart II PCR SuperMix kit (Quantabio, Beverly, MA, USA), the same MODVspecific primers at a final concentration of 300 nM, and the following cycling
parameters: 5 min at 95°C followed by 40 cycles of 15 s at 95°C and 1 min at
60°C. Amplification of the expected gene product was observed using agarose
gel electrophoresis.
Quantification of Viral Loads
Using RT-qPCR
Absolute quantities of viral cDNA collected from select tissues were
assessed using RT-qPCR and MODV-specific primers that recognize a region
contained within the NS5 gene of the viral genome (66). To begin, the
amplification efficiency of these primers were assessed by performing qPCR on
1:10 dilutions of reverse-transcribed viral RNA extracted from stock MODV
suspensions. Following amplification efficiency optimization, qPCR analysis was
conducted by combining 2 µL of viral cDNA template with 10 µL of PerfeCTa
SYBR FastMix (Quantabio, Beverly, MA, USA), 2 µL of forward and reverse
primers each at 3 µM, and 6 µL of nuclease-free water for a total final reaction
volume of 20 µL. Thermocycling was carried out on a CFX384 Touch (BioRad,
Hercules, California, USA) with the following conditions for both amplification
efficiency tests as well as analysis of collected samples: initial denaturation step
at 95°C for 10 min followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. The
generation of a melt curve clarified the production of a single amplicon. Finally,
1:10 serial dilutions of stock MODV cDNA were used to generate four standard
curves from which the means were used to represent the tissue culture infective
dose 50 (TCID50) “equivalent titer” of recovered viral RNA.
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Virus Isolation from Select
Tissues
Following homogenization, tissue sample supernatants were prepared for
virus isolation by first creating suspensions containing 30% volume/volume (v/v)
fetal bovine serum (FBS; Corning, Corning, NY, USA). All samples were then
plated in triplicate on subconfluent layers of Vero E6 cells and incubated for 2.5
hours at 37°C and 5% CO2. Positive controls contained 1:10 dilutions of stock
MODV in 1x PBS and 30% v/v FBS while negative controls contained 30% v/v
FBS in 1x PBS alone. Following incubation, all samples and control inoculums
were removed, and cell monolayers were washed once with 1x PBS. Complete
DMEM culture media containing 2% v/v FBS was added to all wells, and plates
were incubated at 37°C and 5% CO2 for a maximum of 14 days or until negative
controls demonstrated any signs of senescence. Samples were scored as
positive for virus isolation if at least two of three wells indicated clear signs of
CPE. The same procedure, as described above, was utilized to detect infectious
virus in blood sera and urine (examined at a 1:10 dilution) samples given sample
availability for all infected animals in this study.
Sample Collection and
Preparation for
Examination
of Immune
Genes
Liver, spleen, kidney, and brain tissues were collected from infected
(biological triplicates) and mock-infected (biological replicates) deer mice and
hamsters at days 1, 6, and 10 post-infection and to examine immune gene
expression. In one instance, a hamster was euthanized early (day 7 instead of
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day 10) due to apparent morbidity secondary to experimental infection; data
collected for this hamster was still grouped with others from the day 10 collection
timepoint. All specimens collected at the time of necropsy were immediately flash
frozen in liquid nitrogen and held at -80°C until further use. Using a MiniBeadbeater tissue disrupter (Biospec, Bartlesville, OK, USA), approximately 30
mg of frozen tissue were added to a 1.5 mL snap-cap tube containing TRK lysis
buffer (E.Z.N.A Total RNA kit, Omega Bio-Tek, Norcross, GA, USA),
zirconia/silica beads, and 20 µL/mL of β-mercaptoethanol. Following tissue
homogenization, entire suspensions were transferred to a QiaShredder column
(Qiagen, Germantown, MD, USA) and centrifuged at 14,000 x g for 8 min at 4°C
to further mechanically lyse cells and pellet cellular debris. After spinning,
supernatants were carefully removed and utilized for RNA extraction, as
described below.
RNA Extraction and cDNA
Synthesis
Total cellular RNA was extracted from tissue homogenate supernatants
using an E.Z.N.A Total RNA kit (Omega Bio-Tek, Norcross, GA, USA) according
to the manufacturer’s protocol. RNA extracts (eluded in 50 µL of nuclease-free
water) were assessed for concentration and purity using a Nanodrop 2000
spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA). For any
samples with 260/280 or 260/230 absorbance ratios below 1.8, an RNA cleanup
protocol was utilized in which samples were first q.s.’d to 50 µL with nucleasefree water before adding 5 µL of 3M sodium acetate (pH = 5.5) and 50.0 µL of
room temperature isopropanol. Samples were incubated at room temperature in
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the dark for 20 min before centrifuging at 4°C for 10 min at 14,000 x g to pellet
RNA. Pellets were washed three times with ice-cold 70% ethanol, tubes were left
open in an RNA hood for any remaining alcohol to evaporate, and finally, pellets
were resuspended in 50 µL of fresh nuclease-free water and reanalyzed for
purity and concentration. To determine RNA integrity, random samples were
selected and run through agarose gel electrophoresis. Prior to cDNA synthesis,
all samples were treated for genomic DNA contamination by using a PerfeCTa
DNase I removal kit (Quantabio, Beverly, MA, USA) according to the
manufacturer’s protocol. In brief, 1 ug of total RNA was mixed with 0.5 µL (1 U) of
recombinant DNase I, 1 µL of reaction buffer, and sufficient nuclease-free water
to constitute a final reaction volume of 10 µL. Samples were incubated for 30 min
at 37°C and then returned immediately to ice. 1 µL of DNase Stop Buffer
(provided in the same kit) was added to each sample, and reactions were
incubated at 65°C for 10 min to halt enzymatic activity of the DNase. Finally, firststrand cDNA was synthesized by mixing the entire DNase-treated reaction with 4
µL of qScript cDNA SuperMix (Quantabio, Beverly, MA, USA) and 5 µL of
nuclease-free water followed by incubation at 25°C for 10 min, 42°C for 30 min,
and then 85°C for 5 min.
Immune Gene Expression
Analysis
Prior to immune gene expression analysis, all of the primers used for this
study were first analyzed for amplification specificity and efficiency using
endpoint PCR and RT-qPCR, respectively. For the former, a minimum of two
experimental samples were utilized to conduct endpoint PCR using 2 µL of cDNA
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template and an AccuStart II PCR SuperMix kit (Quantabio, Beverly, MA, USA)
according to the manufacturer’s protocol. Amplification of a single gene product
at the expected amplicon size was observed using agarose gel electrophoresis.
Primers were then assessed for amplification efficiency by conducting RT-qPCR
on 1:10 dilutions of the same template cDNA. All primers used for this study were
either recovered from published literature or manually designed by T. Sherman
with the aid of PrimerQuest and OligoAnalyzer (IDT). Details of all primer
sequences, amplification efficiencies, and gene accessions can be found in
Tables 4.1 and 4.2.
Following satisfactory internal validation measures, analysis of immune
gene RT-qPCR was conducted by combining 2 µL of template cDNA (diluted to
10 ng/µL) with 5 µL of SsoAdvanced SYBR Supermix (BioRad, Hercules,
California, USA), 2 µL of forward and reverse primers each at 2 µM, and 1 µL of
nuclease-free water for a final total reaction volume of 10 µL. All primer pairs
were utilized at a final concentration of 200 nM except for the hamster primers for
IL-6 and IFN-γ, which were utilized at final concentrations of 400 nM and 100 nM,
respectively (water volumes adjusted accordingly to retain a final total reaction
volume of 10 µL). All samples were run on a CFX384 Touch thermocycler
(BioRad, Hercules, California, USA) with the following conditions: initial
denaturation step at 95°C for 10 min followed by 40 cycles at 95°C for 15 s and
60°C for 1 min. Additionally, melt curves were generated for each sample, as
described above. Relative gene expression was calculated using the
comparative Ct method (i.e. ΔΔCt) as proposed by Livak and Schmittgen
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whereby immune genes were first normalized against the constitutivelyexpressed β-actin gene (ΔCt) and then calibrated against the ΔCt of mockinfected controls (ΔΔCt) (252). Finally, relative gene expression was depicted as
the mean fold change (2-ΔΔCt) ± standard error of the mean (SEM) between
infected and mock-infected animals at each of the previously described collection
timepoints. Samples that did not generate a Ct value were given a default value
of 40.
Statistical Analysis
Log10 transformations were first applied to all relative expression values
prior to any downstream statistical analysis. The statistical software SPSS v25.0
(IMB, Armonk, New York, USA) was used to conduct a MANOVA examining
significant differences in the relative expression values of cytokine genes
between species among select tissues at distinct collection timepoints. As well,
separate MANOVA tests were run for each species of animal to examine
differences in gene expression profiles within groups when tissues and collection
timepoints are held as fixed factors. Independent samples t-tests were conducted
using PRISM v8.3.1 (Graphpad, LaJolla, CA, USA) to determine whether the
expression of particular genes differed significantly between species within a
particular collection tissue and timepoint. Finally, Mann-Whitney tests were
conducted in PRISM to determine whether viral loads differed significantly
between species in a particular tissue over time. For all analyses, significant
differences between groups were evaluated with an alpha significance of 0.05.
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Table 4.1: Sequence data and amplification efficiencies for deer mouse
primers.
Target Primer Sequence (5’ to 3’)
β-Actin
Fw GCTACAGCTTCACCACCACA
Rv TCTCCAGGGAGGAAGAGGAT
Oas1b
Fw CAGTATGCCCTGGAGCTGC
Rv GTACTTGGTGACCAGTTCC
IFN-γ
Fw ACAGCAGTGAGGAGAAACGG
Rv GACAGGCGGTACATCACTCC
TNFα
Fw GGGCTGTACCTCGTCTACTC
Rv ACAGGAGGTTGACTTTGTCC
TGFβ
Fw CGTGGAACTCTACCAGAAATACAGC
Rv TCAAAAGACAACCACTCAGGCG
IL-6
Fw CCATCCAACTCATCCTGAAAGC
Rv CCACAGATTGGTACACATAGGCAC
IL-10
Fw CAGACCTACACGCTTCGAG
Rv CCCAGGTAACCCTTAAAGTCC
MODV-NS5
Fw CCAGGACAAGTCATGTGGTAGC
Rv TCCCAAAGATGTTCCTCACCTT
able 3

Size

R2

Eff. (%)

Gene Accession

Reference

123

1.000

102.0

XM_006998174.2

Mallarino et
al., 2016 (253)

111

0.998

98.3

XM_006970848.1

This study

115

0.970

94.7

AY289494.1

This study

121

0.999

100.4

XM_006995235.2

This study

96

0.999

95.6

XM_006988036.2

Schountz et
al., 2012 (190)

101

0.999

96.1

AY256518.1

Schountz et
al., 2012 (190)

128

0.999

111.2

XM_006995328.2

This study

101

0.998

107.5

NC_003635.1

Leyssen et al.,
2001 (66)
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Table 4.2: Sequence data and amplification efficiencies for hamster
primers.
Target Primer Sequence (5’ to 3’)

Size

R2

Eff. (%)

Gene Accession

Reference

β-Actin
Fw GCTACAGCTTCACCACCACA
Rv TCTCCAGGGAGGAAGAGGAT
Oas1b

123

1.000

102.4

XM_013120404.2

Mallarino et al.,
2016 (253)

Fw CAGTATGCCCTGGAGCTGC
Rv GTACTTGGTGACCAGTTCC

111

0.999

103.5

XM_013119795.2

This study

130

1.000

104.2

AF034482.1

Espitia et al.,
2014 (243)

79

0.998

97.7

XM_005086799.3

Espitia et al.,
2014

63

1.000

100.7

XM_013125593.2

Zivcec et al.,
2011 (234)

78

1.000

112.4

XM_005087110.2

Zivcec et al.,
2011

194

1.000

99.5

XM_021232886.1

Espitia et al.,
2014

101

0.998

107.5

NC_003635.1

Leyssen et al.,
2001 (66)

IFN-γ
Fw TGTTGCTCTGCCTCACTCAGG
Rv AAGACGAGGTCCCCTCCATTC
TNFα
Fw TGAGCCATCGTGCCAATG
Rv AGCCCGTCTGCTGGTATCAC
TGFβ
Fw TGTGTGCGGCAGCTGTACA
Rv TGGGCTCGTGAATCCACTTC
IL-6
Fw CCTGAAAGCACTTGAAGAATTCC
Rv GGTATGCTAAGGCACAGCACACT
IL-10
Fw GGTTGCCAAACCTTATCAGAAATG
Rv TTCACCTGTTCCACAGCCTTG
MODV-NS5
Fw CCAGGACAAGTCATGTGGTAGC
Rv TCCCAAAGATGTTCCTCACCTT
Table 4

Results
Deer Mice and Hamsters Exhibit
Differential Modoc VirusInduced Clinical
Outcomes
Both deer mice and hamsters demonstrated susceptibility to
intraperitoneal challenge with MODV although the clinical outcomes of infection
differed. Over the 10 day experimental period, none of the deer mice
demonstrated any distinguishable signs of morbidity as characterized by ruffled
fur or piloerection, fluid discharge from the nose, mouth or eyes, hematuria,
muscle weakness, tremor, or flaccid paralysis, general lethargy and changes in
behavior or significant weight loss (Figure 4.1). In contrast, hamsters began to
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exhibit gross organ pathologies beginning at day 4 post-infection in the form of
splenomegaly and epididymitis/orchitis in one of the three individuals euthanized
at that timepoint (Figure 4.2). On day 7, one female (H16) was euthanized three
days ahead of the predetermined schedule of serial euthanasia due to morbidity
in the form of total limb paralysis, obvious tachypnea, crusted blood in one nare,
and apparent incontinence. Two more hamsters developed similar signs (i.e.
extreme lethargy, weepy, squinting eyes with negligibly intact corneal reflexes
and quivering front limbs) of disease by day 8 and were euthanized immediately
(which happened to coincide with the predetermined schedule). Finally, by day
10, the last two remaining hamsters presented with extreme lethargy, slow/weak
reflexes in the front limbs, splenomegaly, orchitis, and extreme weight loss. Thus,
6/18 (33.3%) infected hamsters demonstrated some form of gross anatomical
pathology or clinical manifestation of disease within the 10 day experimental
period. For both the deer mice and hamsters, none of the uninfected controls
presented with any signs of illness throughout the investigation.
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Figure 17

Figure 4.1: Weight gain or loss in deer mice (left) and golden hamsters
(right) over the experimental period. Each data point represents the weight for
a particular infected individual at that timepoint or the mean (+/- SEM) weight of
uninfected individuals at the same timepoint (n = 2). Of particular note is the rapid
loss of weight in one hamster (H16) which corresponds with clinical signs of
disease and subsequent early termination.
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Figure 18

Figure 4.2: Signs of gross pathology in infected hamsters. Instances of
epididymitis (left; day 4 post-infection) and orchitis (right; day 8 post-infection)
observed in hamsters infected with MODV.
Modoc Virus Replication
Kinetics Differ Among
Various Tissues in
Deer Mice and
Hamsters
To assess for differences in viral replication kinetics between deer mice
and hamsters, RT-qPCR was utilized to quantify the levels of MODV RNA
expressed in select tissues and fluids over the experimental duration (Figure
4.3). To this end, it was discovered that MODV RNA is generally recovered at
higher levels in the spleen and liver of infected deer mice as compared to the
higher levels recovered from the sera, urine, brain, and kidneys of infected
hamsters. Further, it was curious to find that in all of the tissues and fluids
examined levels of MODV RNA began to increase by day 4 in hamsters while the
same timepoint generally marked the beginning of decreased levels in deer mice
(save for the spleen and liver, which depicted a slight increase of viral RNA on
days 4 and 6 post-infection, respectively).
More specifically, levels in the sera were similar at the first timepoint of
sampling but began to diverge around day 4 post-infection. By day 6, peak levels
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of MODV RNA were reached in hamster sera, which differed significantly from
those found in deer mice. Interestingly, levels then begin to decline in hamsters
around day 8 concomitant with a very slight increase in deer mice. In the urine,
levels differed significantly at the first timepoint of collection and then increased
in hamsters around day 4 while remaining relatively lower in deer mice (save for
one individual on day 6). Likewise, RNA levels recovered from brain
homogenates in deer mice were significantly higher at the first timepoint of
collection; however, quantities of MODV RNA then spiked in the brains of two out
of three individuals at both day 6 and 8 post-infection and remained higher than
deer mice in all three hamster bioreplicates at day 10 post-infection. Infectious
virus was recovered from at least two of three bioreplicates in the brains of
infected deer mice on days 6, 8, and 10 post-infection but not from the sera (in
total, 2/3 individuals on day 8 and 3/3 individuals on day 10) or urine (all
individuals) of any deer mice. In the hamsters, no infectious virus was recovered
from the brain or sera of any individuals, while infectious virus was recovered
only from one individual on day 10 post-infection.
Following similar trends in the urine and brain, levels of viral RNA in the
kidneys where initially significantly higher in the deer mice. By day 4, though,
levels began to increase in the hamsters and reached a significant peak on day 8
before exhibiting a rapid decline. At all collection timepoints infectious virus could
be recovered from at least two of three bioreplicates in hamster kidney
homogenates (the same was not true of deer mice kidney homogenates, for
which successful virus isolation occurred in only two of three bioreplicates on
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days 8 and 10 post-infection). In the spleen, one of three hamster bioreplicates
demonstrated high levels of MODV RNA on day 4. Besides this, levels remained
marginally higher in deer mouse spleens with a peak on day 6 followed by a
decline which remained significantly higher than the hamsters on day 10.
Infectious virus was recovered from at least two of three deer mouse
bioreplicates on days 8 and 10 but not from any hamsters. Finally, levels of viral
RNA in the liver of deer mice remained consistently higher through the
experimental period and displayed a significant difference on day 10 postinfection; however, while infectious virus could only be recovered from two of
three deer mouse bioreplicates on days 8 and 10, viral isolation was successful
for at least two of three hamster bioreplicates at all timepoints sampled. The
above considered, it was found that the levels of MODV RNA ultimately only
differed significantly (p ≤ 0.05) between species over time only in the liver and
sera. It may be, though, that the high variance experienced between
bioreplicates at nearly every timepoint could have contributed to a loss of
significance that might otherwise be found were the sample size increased.
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Figure 19

Figure 4.3: Viral RNA loads detected in select tissues and fluids of deer
mice (squares) and hamsters (circles) over the experimental period. Viral
RNA was quantified using two-step RT-qPCR and translated into TCID 50
“equivalent titers.” Each data point represents the mean (+/- SEM) viral load
recovered from infected replicates at each timepoint (n = 3). Asterisks represent
a significant difference in RNA loads between deer mice and hamsters at a
particular timepoint as determined by Mann-Whitney tests. Data points with red
squares or dots represent instances in which infectious virus was successfully
isolated for at least two of three bioreplicates.
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Expression of the Antiviral
Cytokine Interferon-γ
Differs Between
Deer Mice and
Hamsters
Given the predicted variance that may occur between gene expression
levels, a log10 transformation was first applied to all relative expression values
prior to any downstream statistical analysis. Once transformed, a Shapiro-Wilk
test for normality confirmed that all relative expression values were normally
distributed in deer mice (p ≥ 0.11) except for one instance (TGFβ in liver tissues;
p = 0.04). Likewise, all relative expression values in hamsters were normally
distributed following transformation (p ≥ 0.09) save for IFN-γ expression in the
spleen (p = 0.02) and brain (p = 0.21) as well as the expression of IL-10 in the
brain (p = 0.04).
To determine whether the observed profiles of IFN-γ, TNFα, IL-6, IL-10,
and TGFβ expression were statistically meaningful, multivariate analysis of
variance (MANOVA) tests were used to first examine gene expression in the
deer mice, then in the hamsters, and finally in both species together. As well,
independent samples t-tests were used to compare the mean levels of cytokine
gene expression at specific timepoints between each species; however, multiple
corrections for these t-tests were not included (Figure 4.4). For each species, it
was discovered that there was indeed a significant difference in the profile of
cytokine genes expressed between tissues over time (deer mice, p = 0.01;
hamsters, p = 0.01). In the deer mice, between-subjects effects with corrected
models revealed that IFN-γ, TNFα, and TGFβ were significantly differentially
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expressed when both tissue and collection timepoint are treated as cofactors.
Curiously, the same analysis conducted with data collected from the hamsters
demonstrated that IFN-γ, TNFα, IL-6, and IL-10 were significantly differentially
regulated, but TGFβ was not. When a single MANOVA was used to compare the
profiles of expressed genes between species, collection timepoints, and tissues,
it was again found that there was a significant difference in the relative
expression of all genes over time between tissues and species (p = 0.02). In this
case, however, only the expression of IFN-γ differed significantly (p = 0.01).
When comparing the expression of individual genes between species, it
was interesting to find that in some cases, the patterns of expression between
tissues corresponded with the levels of MODV RNA detected. For example,
expression of IFN-γ was initially higher for deer mice in the kidneys, spleen, and
liver, although not the brain. Along with this, IFN-γ expression remained at an
elevated state in deer mice relative to hamsters in the spleen and liver, both of
which were found to contain marginally higher levels of viral RNA. In a similar
fashion, higher relative expression of IFN-γ in the kidneys (past day 1) and brains
of infected hamsters matches the elevated levels of viral RNA recovered from
those same tissues. Indeed, it seems intuitive that antiviral cytokines such as
IFN-γ would be highly expressed in instances of higher viral loads; granted, these
trends may also be highly tissue-dependent as suggested by examining one
particular hamster which demonstrated much higher levels of both viral RNA and
IFN-γ on day 6 in the kidneys but only high levels of viral RNA (and the lowest
expression of IFN-γ among biotriplicates) in the brain at the same timepoint.
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Aside from IFN-γ, all other genes were found to be significantly
differentially expressed between species; however, these cases occurred only in
certain tissues and at particular collection timepoints. For example, expression of
TNFα differed significantly between deer mice and hamsters on day 1 in the
kidneys and brain as well as day 6 in the kidneys and spleen but at no other
timepoints in any tissues. IL-6 only differed significantly at day 10 in the kidneys.
Finally, IL-10 differed significantly in the brain on days 6 and 10. These results
may implicate that while only IFN-γ was shown to be significantly differently
expressed among all tissues between species over time, the differential
expression of individuals genes is likewise a potentially important factor in
determining the outcome of viral infection.
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Figure 20

Figure 4.4: Cytokine gene expression levels as detected by RT-qPCR in
select tissues from both deer mice and hamsters at distinct collection
timepoints. Bars with asterisks denote a significant difference (p ≤ 0.05) in the
expression levels between species at that particular timepoint of collection
(uncorrected for multiple tests). Peromyscus maniculatus is represented by “PM”
(black bars) while Mesocricetus auratus is represented by “MA” (grey bars).
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The Interferon-Stimulated Gene
Oas1b is Significantly
Upregulated in
Hamsters
Using a three-factor analysis of variance (ANOVA), it was discovered that
the interferon-stimulated gene (ISG) Oas1b was significantly differentially
expressed between deer mice and hamsters in select tissues at distinct collection
timepoints (p = 0.03). Namely, relative expression values in the hamster kidney
tissues at all timepoints, as well as in brain tissues at days 6 and 10 postinfection, were much higher than those of deer mice at the same collection
timepoints. In contrast, relative expression values in deer mouse liver tissues
was significantly higher at days 1 and 6 but not at day 10.
Figure 21

Figure 4.5: Expression levels of Oas1b in deer mouse and hamster tissues.
Expression levels of the antiviral effector Oas1b as detected by RT-qPCR in
select tissues from both deer mice and hamsters at distinct collection timepoints.
Bars with asterisks denote a significant difference (p ≤ 0.05) in expression levels
between species at that particular timepoint of collection (uncorrected for multiple
tests). Peromyscus maniculatus is represented by “PM” (black bars) while
Mesocricetus auratus is represented by “MA” (grey bars).
Discussion
The research presented here attempts to take a comparative approach to
elucidate the profile of cytokine genes expressed in previously described
pathogenic and non-pathogenic models of flaviviral encephalitis (7, 8, 96). Using
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MODV, a BSL-2, rodent-borne flavivirus, deer mice and hamsters were
intraperitoneally challenged and serially euthanized to capture the expression of
five cytokine genes (interferon-gamma, IFN-γ; tumor necrosis factor alpha, TNFα;
interleukin-6, IL-6; interleukin-10, IL-10; and transforming growth factor beta,
TGFβ; Figure 4.4) and one antiviral effector gene (2’-5’ oligoadenylate isoform
1b, Oas1b; Figure 4.5) across four tissues (kidneys, spleen, liver, and brain) at
three distinct timepoints (1, 6, and 10 days post-infection). Further, levels of
MODV RNA were quantified within the same tissues at each of the
aforementioned timepoints in addition to 2, 4, and 8 days post-infection (Figure
4.3).
With regard to clinical presentation, no deer mice infected with MODV
demonstrated any signs of gross anatomical pathology or overt disease
throughout the entire experimental duration. These findings both corroborate and
contribute to the very limited handful of previous investigations of deer mice
experimentally infected with MODV by demonstrating that even at the higher-titer
challenge, the deer mice are able to resist pathology (8, 254). In contrast, 6/18
(33.3%) infected hamsters demonstrated some form of pathology similar to the
findings of previous studies (7, 66, 96). In one such case, Adams et al. describe
an experiment in which two hamsters developed bilateral hindlimb paralysis or
complete paralysis with intact corneal reflexes by days 6 and 7 post-infection,
respectively (7). During a separate investigation, Leyssen et al. discovered that
approximately half of MODV-infected hamsters developed (clinically-confirmed)
signs of neurologic disease reminiscent of other encephalitic flaviviruses (e.g.,
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WNV and JEV) within 10 days post-infection (66). Taken together, these studies
and the research presented here support the notion of utilizing hamsters and
deer mice infected with MODV as comparative models of flaviviral encephalitic
disease or resistance, respectively, and provide the impetus to explore the
differential expression of immune response genes to help elucidate these
opposing outcomes.
Past investigations suggest that MODV may differentially replicate in the
spleen, lungs, and salivary-submaxillary glands of deer mice while appearing
more trophic toward the kidneys and brain of infected hamsters (7, 8, 65, 66, 96,
254). Indeed, both viremia and viruria are possible to varying degrees in each
species; however, no studies thus far have directly compared the viral loads in
each model using quantitative methods when both dosage route and infectious
titer are standardized. Having this information may help to further clarify the
tissue tropism and replication kinetics of MODV in these animals while further
providing clues as to how the regional cytokine milieu may influence the outcome
of local or systemic pathologies. One of the aims of this research was therefore
to complement previous studies by resolving this gap in knowledge.
To this end, we found that MODV RNA was generally higher in the spleen
and liver of deer mice as compared to hamsters. In both organs, these levels
correspond with higher expression of IFN-γ and TNFα in deer mice compared to
hamsters at all collection timepoints. Indeed, it is expected that higher levels of
antiviral, proinflammatory cytokines such as these would be associated with
tissues that contain higher burdens of replicating virus. However, it is interesting
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that the levels of IL-6, another proinflammatory cytokine, do not likewise follow
these trends. In contrast, mean expression levels of IL-6 remain lower in the
spleen and livers of infected deer mice at 1 and 6 days post-infection but are
then higher than the expression levels observed in hamsters for both organs by
day 10. In any case, infectious virus was only recovered from at least two of
three bioreplicates on days 8 and 10 in the spleen and liver of infected deer and
from two of three bioreplicates at all collection timepoints in the livers of
hamsters. No successful virus isolations were obtained from the spleens of
infected hamsters.
Generally, higher levels of viral RNA were recovered from the kidneys of
infected hamsters, a finding that is consistent with previous research
demonstrating that MODV displays a trophism toward renal tissues in hamsters
and may persist for long periods of time (e.g., up to 14 months post-infection) (7,
65, 92). As well, infectious virus could be recovered from at least two of three
hamster bioreplicates at all timepoints examine but only on days 8 and 10 with
the deer mice. Unlike gene expression trends observed in the spleen and livers
of deer mice, significantly higher relative expression of TNFα is evident by day 1,
whereas higher levels of IFN-γ do not occur until day 6. Moreover, while IFN-γ is
maintained at higher levels than in deer mice until at least day 10, expression of
TNFα drops significantly by day 6 before increasing slightly by day 10. IL-6
follows a similar trend as TNFα whereby expression is first higher than that of
deer mice, decreases by day 6, and is then significantly higher by day 10. The
implications that these findings in the kidney have on subsequent viruria are
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unclear. Similar to the levels of MODV RNA observed in the kidneys, though,
viral loads are initially higher in the deer mice before falling below that of the
hamsters (save for one individual on day 6) for the remainder of the experiment.
Nevertheless, the fact that infectious virus was only recovered from one
individual (hamster) on day 10 post-infection could be due to an initial replication
eclipse period that needs to be overcome before sufficient infectious virus is
recoverable; this notion is supported by previous investigations with MODV in
which infectious virus is not successfully isolated from the urine until past day 7
following infection via subcutaneous or intranasal route (7, 65)
Expression of IFN-γ in the brains of hamsters was elevated above that of
deer mice on all days. In particular, extreme differences were observed by day 6
and were significant by day 10. Despite the finding that levels of viral RNA were
initially significantly higher in deer mice, levels of viral RNA in hamsters begin to
rise rapidly by day 2, surpassing levels in the deer mice by day 4 and remaining
higher for the remainder of the experiment. This observation matches previous
studies that demonstrate a neurotropism of MODV in hamsters and supports the
high levels of IFN-γ expression in these tissues (7, 66, 96). It is curious, though,
that the levels of MODV RNA recovered from the brains of hamsters displayed
extreme variance concomitant with the levels of variance observed between
expressions of IFN-γ. For example, on day 6, viral RNA was most highly
expressed in one particular hamster, which also expressed the fewest transcript
copies of IFN-γ. This stands in contrast to the data collected from the same
individual in kidney tissues, whereby both the levels of IFN-γ and viral RNA were

142

the highest among the three bioreplicates examined. Expression of TNFα was
likewise higher on days 1 and 6 but not by day 10, whereas IL-6 was more highly
expressed in hamsters than deer mice on day 6 but not days 1 and 10. Finally,
the levels of IL-10 expressed in the brains of infected hamsters notably exceeded
those observed in the deer mice at all timepoint and were significantly higher on
days 6 and 10.
It has been well established that many flaviviruses antagonize the type I
interferon (IFN) antiviral signaling system at multiple levels and may
subsequently inhibit the expression of intracellular, antiviral effector proteins
(123, 126, 267, 268). However, due to the absence of available sequences for
deer mouse and hamster type I IFN transcripts, we choose to examine
expression of Oas1b as a representative IFN-stimulated gene (ISG) to quantify
downstream type I IFN signaling (269). The Oas (2’-5’ oligoadenylate) family of
proteins generally encode enzymes capable of activating latent cytosolic
ribonuclease L (RNAse L), which acts to degrade viral and host transcripts.
Although Oas1b lacks this enzymatic activity and therefore exerts antiviral activity
through other, incompletely understood mechanisms, it has nevertheless been
demonstrated to be protective against flaviviral infections such as WNV (270273). For this study, primers for the Oas1b gene were designed using
homologous sequences found in regions of the Oas1b coding transcripts from
deer mice, golden hamsters, and Mus musculus. Using these primers, it was
interesting to find that significantly higher expression of Oas1b appeared in the
livers of infected deer mice as opposed to the kidneys and brains of infected
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hamsters (Figure 4.5). These patterns roughly coincide with the apparent tropism
of MODV toward these tissues as determined by the quantities of viral transcripts
recovered from each species, although the same trends were not observed in the
spleens of infected animals. Given these outcomes it would appear that MODV
does not antagonize the type I IFN response in the same manner that is
characteristic of some other flaviviruses. Further, the high expression levels of
Oas1b by 24 hours post-infection confirms that both species are capable of
recognizing MODV viral antigens and initiating expression of ISGs within a
timeframe similar to that induced by other flaviviruses such as WNV (125).
Despite these similarities, it is curious that the expression levels in the kidneys
and brains of hamsters far exceed those in deer mice at any timepoint except
day 1 post-infection.
IFN-γ (also known as type II IFN) is a multifunctional, pleiotropic cytokine
that is important in the fight against viruses among various other pathogens
[citations]. It has been cited as one of the most potent activators of macrophages
(particularly those with the classical, or M1 phenotype) and may also induce nitric
oxide (NO) production contaminant with the upregulation of major
histocompatibility complexes (MHC) I and II, all of which aid in the response
against intracellular pathogens (287-289). Indeed, the polarization of immune
effectors toward a phenotype which better targets intracellular invaders
(historically referred to as the TH1 phenotype) is in large part accomplished by
the expression of IFN-γ from activated cells such as helper T lymphocytes (T H)
and natural killer (NK) cells (287, 288). Similarly, TNFα serves myriad roles in
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antimicrobial immunity as well as normal physiologic homeostasis (264). As an
antiviral secreted from activated T cells and macrophages, TNFα elicits fever,
stimulates the expression of acute-phase liver proteins, and may induce
apoptosis in infected endothelial cells (264). Finally, like IFN-γ and TNFα, IL-6 is
another important proinflammatory mediator which may be released from many
cell types, including macrophages and T cells upon stimulation from cytokines
like TNFα (290). As an antiviral, IL-6 further contributes to the febrile response
and may recruit cytotoxic neutrophils to sites of active infection as well as
promoting B cell differentiation and subsequent antibody production (291, 292).
In contrast to the above three cytokines, IL-10 and TGFβ have traditionally been
viewed as immunomodulatory or even immunosuppressive, the expression of
each presumed to mollify sustained inflammatory responses prior to the onset of
immunopathogenic collateral damage (293). The mechanisms through which
these two cytokines function are diverse and incompletely understood, though
examples of putative roles include the suppression of IFN signaling (IL-10) or the
induction of T regulatory (Treg) cell-mediated tolerance (293, 294).
The above considered, the profile of cytokines expressed between deer
mice and hamsters across tissues and over time during infection with MODV
paints an intriguing picture with regard to the outcomes of clinical disease. As
was determined by statistical analysis, IFN-γ appears to exert a particularly
important role in coordinating the early innate immune response as this was the
sole cytokine to demonstrate significance (p = 0.01) when tissue, species, and
timepoint of collection are all held as fixed factors. Moreover, the sheer quantity
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of IFN-γ transcripts detected between deer mice and hamsters (namely in the
kidneys and brain) elicit curiosity for the differential mechanisms which control
the expression of cytokines between these two species. Although the exact
antiviral mechanisms of IFN-γ have only recently been more clearly elucidated
(largely due to the redundant and overlapping downstream effects induced by
other IFNs), it has been demonstrated repeatedly that the protective levels of
IFN-γ exist within a range such that over- or under-expression may lead to
deleterious clinical outcomes (295). For example, it has been shown that intact
IFN-γ signaling is required to promote the protective roles of innate γδ T cells and
primary dendritic cells against infection with WNV (262). On the other hand,
overexpression of IFN-γ may lead to the upregulation of adhesion molecules
such as intercellular adhesion molecule-1 (ICAM-1), a putative binding receptor
for many flaviviruses (126, 146, 296). However, the consequences of this
induced upregulation of ICAM-1 may be flavivirus-specific, as infection by some
flaviviruses (e.g., WNV) appear to upregulate these receptors in a manner
independent of IFN-γ expression (297). In any case, it could be that
discrepancies in the activation of innate pattern recognition receptors (PRRs) by
MODV antigens in deer mice and hamsters leads to differential cytokine
responses, an event that has been documented in other flaviviral systems (26,
174, 298).
The expression of IL-10 in the brains of infected hamsters may be a point
of interest for further investigation given its increased expression at all timepoints
relative to deer mice, the magnitude of expression on days 6 and 10, and
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previous research which has correlated this particular cytokine in both protective
and adverse outcomes of flaviviral infection (namely DENV) (299, 300). Like IFNγ, though, regulation of this cytokine may be highly virus (i.e. serotype) specific,
as some research has shown IL-10 to be elevated only for DENV-2 infection
while apparently being downregulated during infection by DENV-1, 3, and 4
(301). Nevertheless, multiple studies have suggested that excessive production
of IL-10 (as may be witnessed here) could inhibit the protective effects of T cells,
alternatively favoring viral persistence (302-304). To this end, the expression
levels of IL-10 in this study are significant when only tissue and species are
treated as fixed factors in a multivariate analysis (p ≤ 0.00). This may add
support to the notion that regulation of this cytokine does indeed play an
antagonistic role in the productive control of MODV in brains of infected
hamsters.
It is unclear at this time how the patterns of TNFα, IL-6, and TGFβ
influence MODV replication in either deer mouse or hamster tissues. For all of
these, the relative lack of variation in expression suggests that their role under
the parameters of this experiment is less important; however, as there were
some instances of statistical significance, further investigation may be warranted.
As well, assays that examine the circulating protein levels of these cytokines
could be telling, particularly for TGFβ, which is less transcriptionally regulated in
mammalian cells (293, 305).
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Conclusions and Future Directions
This study utilizes two unique rodent models to directly compare the host
response, viral tropism, and cytokine gene expression profiles in select tissues
following infection with a NKV flavivirus. As the putative reservoir hosts of MODV,
deer mice are presumed to share a unique relationship with their viral
counterparts in which a delicate balance has developed between the host
immune response and viral infection (185). This relationship between a virus and
its reservoir holds valuable information when attempting to further understand the
molecular mechanisms in place that prevent illness in the reservoir but lead to
disease when non-reservoir species (such as humans) become infected.
Alternatively, hamsters offer a susceptible and pathogenic model in which the
molecular underpinnings of disease development can theoretically bed
elucidated when the immune response is compared to that of a non-pathogenic
model, and the parameters of experimental infection are standardized.
It is known that the cytokine response is critical to the outcome of flaviviral
clearance, persistence, or clinical pathogenesis (150, 265, 306-309). This study
superficially demonstrates that importance by highlighting the involvement of one
such cytokine, IFN-γ, which was shown to be significantly differentially expressed
across tissues and over time even when variation between individuals was high.
Findings like these may help to provide a link between the early innate immune
response and the subsequent outcome of viral infection, both in terms of
controlling immediate viral burdens as well as eliciting a productive adaptive
response.
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It is our hope that this study will further provide the impetus to continue
work with MODV as a BSL-2 model of flaviviral encephalitis given the
contributions depicted here in accordance with previous research conducted. For
example, Adams et al. demonstrated that MODV-infected hamsters displayed
lesions in the central nervous system (CNS) similar to those described for WNVinfected hamsters (7). However, work by Adams et al. did not include an
investigation of any cytokines expressed during acute infection, a factor which
may strongly influence viral tropism; in this way we hope that our research will
complement what has been conducted in the past.
Another example of the potential to utilize MODV in comparative analyses
against other, more medically-pertinent representatives involves our finding that
MODV may display a tropism toward reproductive tissues (Figure 4.2). This could
be useful given that the recently acclaimed ZIKV has been shown to infect
reproductive tissues in otherwise healthy adults and developing fetuses (153). As
well, using MODV may provide an feasible avenue for further understanding
differences in host sex, which may influence the outcome of viral disease. In our
study, the individuals which demonstrated neurologic involvement (via limb
paralysis) were consistently female. As it has been additionally demonstrated
that Norway rats infected with Seoul virus (SEOV) demonstrate differential innate
responses dependent upon host sex, it could be that continued investigation of
these instances could help better guide the development of antiviral therapies
administered to either human males or females (310).
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Finally, future research may benefit from using MODV to further
investigate the aspects between host and viral, which lead to persistence
following the initiation of the innate response. For example, previous studies with
MODV have demonstrated that the virus will persist in the kidneys of infected
hamsters for long periods of time in a manner similar to that of WNV and St.
Louis encephalitis virus (SLEV) (311, 312). Neither of these latter studies,
however, included the examination of cytokines, which may allow for viral
persistence, something which we hope could be supplemented by studies like
ours.
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CHAPTER V
CONCLUSIONS
Flaviviruses (family Flaviviridae) comprise a taxonomic collective of
globally-distributed viruses that may elicit a vast range of clinical pathologies. In
particular, members of the genus Flavivirus constitute a significant portion of all
arthropod-borne viruses (i.e. arboviruses), viruses that are carried and
transmitted to new susceptible hosts by insects such as ticks and mosquitoes.
For perspective, dengue virus (DENV), now considered to be the most common
arbovirus in the world, infects more than 390 million individuals annually (95%
confidence interval) across 129 countries and leads to clinical disease in
approximately 96 million and death in nearly 40,000 (10, 279, 313). Other
flaviviruses of medical relevance include Japanese encephalitis virus (JEV),
yellow fever virus (YFV), Zika virus (ZIKV), and West Nile virus (WNV), all of
which are vectored by the prevalent Culex or Aedes genera of mosquitoes. Tickborne encephalitis virus (TBEV) and Powassan virus (POWV) are additionally of
concern and are transmitted by ticks such as those of the Iodexes complex.
Unfortunately, there are no FDA-licensed antivirals for any of the known
flaviviruses. While vaccines exist for some (e.g., YFV and JEV), they are often
expensive or entirely inaccessible to the populations that need them most (those
in tropical, underdeveloped nations). Moreover, ongoing changes to global
climate have led to the range expansion of ticks and mosquitoes, a factor which
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is compounded by other anthropogenic practices such as waste plastic and tire
production (1, 84, 85, 314). Indeed, the Centers for Disease Control and
Prevention (CDC) have estimated that diseases caused by arthropods in the US
have tripled in the last 13 years (Figure 5.1) (315). Likewise, although not yet
endemic in the US, it has been proposed that global cases of DENV infection
have increased 30-fold in the last 30 years (316). In light of this, there exists a
pertinent need for continued research with flaviviruses to better inform the
science behind disease prevention and mitigation.

Figure 22

Figure 5.1: Increased prevalence of vector-borne diseases in the US over
the last 13 years. Recent years have witnessed an alarming increase in the
infection incidence of diseases carried by arthropod vectors such as ticks,
mosquitoes, and fleas. Although there are many factors that may influence this
trend, it is believed that warming global temperatures have led to increased
ranges for the insects that vectors diseases such as ZIKV, WNV, and DENV
(315).
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Although Modoc virus (MODV) strictly infects vertebrate hosts and is
therefore not considered an arbovirus, it has nevertheless been classified as a
member of the Flavivirus genus in light of the virion structure, viral genome
organization, and replication strategies it employs (17). As a biosafety level-2
(BSL-2) virus, MODV has been utilized in attempts to elucidate the discrete
characteristics which promote or restrict replication in vertebrate or invertebrate
hosts, respectively (52, 98, 100). While MODV is not typically considered a
concern to general public health, both disease and subclinical infection have
been documented in humans (6, 101). Further, a small handful of studies have
used MODV to investigate aspects of neurologic disease in Syrian golden
hamsters, a rodent model that recapitulates instances of flaviviral encephalitis
such as those caused by JEV, WNV, or St. Louis encephalitis virus (SLEV) (95,
96). Finally, there has been interest in the use of deer mice to better understand
the immunological underpinnings which allow for this rodent to act as a reservoir
host for MODV as well as a slew of other human viral and bacterial pathogens
without the development of any apparent disease (188, 190, 210, 215, 246, 317).
For these reasons, the research presented here attempts to create a novel model
for the investigation of flaviviral disease by directly comparing the host response,
viral replication kinetics, and subsequent immune gene expression in deer mice
and golden hamsters acutely infected with MODV. This research is novel in that it
is the first to investigate the profile of immunological signals (i.e. cytokine and
effector gene transcripts) expressed during infection with MODV concomitant
with the patterns of viral replication in select host tissues over time.
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Results from this research corroborate previous studies demonstrating
that experimental infection of deer mice with MODV is non-pathogenic while
hamsters experience clinical signs of disease similar to human cases of flavivirus
illness with neurologic involvement (e.g., rapid weight loss followed by paralytic
syndromes). Analysis with RT-qPCR indicates that MODV RNA can be
recovered from the kidneys, spleen, liver, brain, urine, and sera of all
intraperitoneally-infected animals as early as 24 hours post-infection and persists
until at least 10 days post-infection. While higher average levels of viral RNA
were observed in the spleen and liver of deer mice, higher quantities were
recovered from the kidneys, brain, sera, and urine of hamsters. Along with this,
infectious virus could be recovered from all tissues (but not the sera or urine) of
deer mice by day 8 post-infection; this finding is expected given that MODV may
develop persistent and transferrable infections in deer mice under natural
conditions as the putative reservoir hosts. On the other hand, infectious virus
could be recovered from the kidneys and liver of multiple hamsters at all
timepoints sampled, suggesting that acute infection in less controlled in these
rodents as compared to deer mice.
The examination of select cytokine transcripts in the same tissues of
infected animals depicts an inflammatory response characteristic of those
anticipated by the induction of viral pathogens (e.g., elevation in cytokines such
as IFN-γ which drive polarization of an antiviral T H1 response). In contrast to one
another, however, the quantity and pattern of transcripts expressed between
deer mice and hamsters varied radically, especially in brain tissues. Of note, IFN-
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γ was shown to be significantly differentially expressed when tissue type,
collection timepoint, and host species are treated as fixed factors. This may
warrant further investigation given that IFN-γ has been implicated in both
protective as well as deleterious outcomes of flaviviral infection (262, 263). As
well, the increased expression of IL-10 at all timepoints in the brains of infected
hamsters relative to deer mice is curious given that expression levels are
statistically significant when only tissue type and host species are treated as
fixed factors and that, like IFN-γ, this immunomodulatory cytokine has correlated
with both positive and negative outcomes of viral disease (143, 300).
Future research utilizing the models presented here may wish to include a
more complete examination of the cytokine (and chemokine) genes expressed
during infection, perhaps through the use of RNA sequencing and transcriptomic
analyses. Additionally, it would be important to include assays which examine the
levels of translated proteins corresponding to expressed genes of interest;
however, this may be difficult given that few reagents (e.g., antibodies) are
commercially available for deer mouse and hamster proteins which are poorly
cross-reactive with those of Mus and Rattus species (234). Alternatively, there is
evidence to suggest that other non-proteinaceous inflammatory (or antiinflammatory) mediators could influence the outcome of infectious disease. To
this end, lower serum levels of the lipid messenger sphingosine 1-phosphate
have been correlated with decreased vascular barrier integrity and increased
disease presentation during infection with DENV (318). Likewise, mediators
generated from polyunsaturated fatty acids (e.g., resolvins and protectins) have
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been demonstrated to aid in mitigation of the inflammatory response; however,
how these molecules function in the context of flaviviral disease is not yet clear
(319).
Taken together, the findings reported in this dissertation describe a
system in which differences in the kinetics of viral replication, as well as the
subsequent host immune response, can be directly compared in two unique
rodent models of infection. In it of itself, a system like this may help to further
clarify the immunological paradigms which influence the outcome of clinical
disease during infection with representative zoonotic RNA viruses. Moreover,
there is hope that research such as this may contribute to the greater scientific
community’s understanding of flaviviral disease and the differential host factors
which may either prevent or promote overt pathologies. In particular, the
assessment of cytokine profiles during acute durations of infection may help to
better define parameters of disease prognosis or aid in the development of
vaccines which induce robust and durably protective immunity.
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APPENDIX A
MELT CURVE ANALYSES FOR MODV-SPECIFIC
AND β-ACTIN PRIMERS

183

Melt curve analyses for MODV-specific (top) and β-actin primers (bottom)
used in this study. Melt curves for both analyses were generated by
incrementally increasing the thermocycler temperature by 0.5°C from 65°C to
95°C every 5 seconds. The generation of melt curves helps to clarify the
production of a single amplicon.
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APPENDIX B
GRAPHS OF RELATIVE GENE EXPRESSION
WITH BIOREPLICATES AT EACH
TIMEPOINT REPRESENTED
(DEER MICE)
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186

Relative gene expression values with bioreplicates at each timepoint
represented. These graphs are intended to demonstrate the variance between
bioreplicates from which tissues were collected at each timepoint. Note that the
experimental design of this study was cross-sectional; therefore, “DM1, 2, and 3”
at each timepoint does not indicate repeated-measures sampling, but rather
represents each of the three individuals euthanized at that particular collection
timepoint. Data are displayed on a logarithmic scale in order to capture values
from all individuals.
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APPENDIX C
GRAPHS OF RELATIVE GENE EXPRESSION WITH
BIOREPLICATES AT EACH TIMEPOINT
REPRESENTED (HAMSTERS)
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189

Relative gene expression values with bioreplicates at each timepoint
represented. These graphs are intended to demonstrate the variance between
bioreplicates from which tissues were collected at each timepoint. Note that the
experimental design of this study was cross-sectional; therefore, “H1, 2, and 3” at
each timepoint does not indicate repeated-measures sampling, but rather
represents each of the three individuals euthanized at that particular collection
timepoint. Data are displayed on a logarithmic scale in order to capture values
from all individuals.
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APPENDIX D
EXPERIMENTAL INFECTION OF DEER MICE
AND HAMSTERS WITH MODOC VIRUS:
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